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ABSTRACT 
Decidualization, the differentiation of endometrial stromal cells, is essential for a 
successful pregnancy. Although the steroid hormones estrogen (E) and progesterone (P) are 
known to control decidualization, the precise mechanisms via which these hormones act to 
control this differentiation process are poorly understood. We used primary cultures of human 
endometrial stromal cells (HESC) to analyze the role of estrogen receptor alpha (ESR1) and 
progesterone receptor isoforms (PRA and PRB) in human decidualization. 
Previous studies established that HESC, when treated with the differentiation cocktail 
containing E, P, and a cyclic adenosine monophosphate (cAMP) analog, cease proliferation and 
undergo differentiation. In the present study, when ESR1 expression was silenced, the HESC 
continued to proliferate in the presence of the differentiation cocktail and their differentiation 
was severely inhibited. Gene expression profiling revealed that, in the absence of ESR1, the 
expression levels of several cell cycle regulatory factors were increased and those of specific cell 
cycle inhibitors were decreased. Our study also revealed that ESR1 promoted the expression of 
key regulators of HESC differentiation (PGR, FOXO1 and WNT4). Expression of these targets 
was dependent on the addition of cAMP, suggested a functional link between cAMP and ESR1 
signaling. Using a proteomic approach, we identified MED1 as a target of cAMP-activated 
protein kinase (PKA) during HESC differentiation. The PKA-dependent phosphorylation of 
MED1 enhanced its ability to interact efficiently with ESR1. Furthermore, loss of MED1 
expression inhibited HESC differentiation with parallel impairment in the expression of a subset 
of ESR1 target genes. Addition of cAMP increased recruitment of MED1 to the ESR1 binding 
regions of a target gene (WNT4). Collectively, these results indicated that, during 
decidualization, ESR1 suppresses HESC proliferation and promotes their differentiation via 
interactions with MED1, which is activated in response to cAMP signaling. 
Progesterone, acting through its receptors, is essential for the precise regulation of the 
endometrial processes required for a successful pregnancy, including decidualization. However, 
the specific roles of the progesterone receptor isoforms, PRA and PRB, during endometrial 
differentiation in the human have remained unknown. A major focus of my project was to shed 
light on the roles of the receptor isoforms by identifying their cistromes and correlated gene 
expression profiles during differentiation of human stromal cells. We expressed PRA and PRB 
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individually after silencing endogenous progesterone receptors so that the roles of the isoforms 
could be analyzed independently as well as jointly. Identification of the cistromes of PRA and 
PRB using chromatin immunoprecipitation (ChIP) followed by high throughput sequencing 
(ChIP-seq), revealed that PRB cistrome was larger, covering that of PRA, at an early time point 
of in vitro differentiation of human endometrial stromal cells. Our de novo motif analysis 
showed that, both isoforms bind to the same DNA sequence motif, progesterone response 
element (PRE). In addition to the PRE, they had both common and distinct nearby motifs where 
other transcription factors might bind. Many molecules previously identified as progesterone 
target genes and known to regulate stromal differentiation were found to contain PRA and PRB 
binding sites, including BMP2, HAND2 and HOXA10,  confirming the validity of our method.   
Our comprehensive gene expression analysis suggested that PRA and PRB regulated 
overlapping and distinct sets of genes. When PRA and PRB were expressed together, PRB was 
the prevalent isoform, while both isoforms influenced each other’s transcriptional activity. Our 
findings suggested that PRB was a more effective transcription factor than PRA in human 
stromal cell differentiation by the extent to which it interacted with the genomic binding sites 
and regulated downstream gene networks. Collectively, our first line of analysis provided an 
insight into the early molecular mechanisms regulated by progesterone receptor isoforms during 
stromal differentiation. With this study, we confirmed some of the known roles of progesterone, 
such as regulation of angiogenesis, proliferation and apoptosis. We could also distinguish 
signaling networks downstream of each isoform and identify new molecules, such as IRS2, as 
possible direct targets of progesterone signaling for the establishment of a successful pregnancy.  
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CHAPTER I 
INTRODUCTION 
Uterine functions during early pregnancy  
Endometrium is a unique adult tissue because of its capacity to proliferate and 
differentiate in a cyclical fashion during each menstrual cycle. The cycle of proliferation, 
differentiation, regression and regeneration is repeated hundreds of times during the 
reproductive years of a female [1-3]. This unique feature of endometrium is actually a 
preparation for a possible pregnancy which is synchronized with the cell division cycles of a 
fertilized egg and its migration from the fallopian tubes to the lumen of the uterus so that the 
endometrium is ready or “receptive” when the blastocyst arrives for implantation (Fig. 1) [4, 5]. 
Implantation is an essential step for a successful pregnancy [4].  It proceeds through distinct 
phases of maternal-embryo interactions, involving apposition, attachment and invasion stages 
[5]. The attachment of the embryo to the uterine epithelium is accompanied by a dramatic 
transformation of the underlying stromal compartment [5]. During this process, known as 
decidualization, fibroblastic, non-secretory stromal cells undergo differentiation into 
morphologically and functionally distinct decidual cells. [3-5]. The decidual tissue supports and 
nourishes the embryo until placenta formation. Additionally, it modulates local immune 
response to protect the embryo and regulates trophoblast invasion [5-7].  
 
  
Figure 1.1: Diagram of the uterus and the journey of the blastocyst. 
Adapted from http://proctornet.com/text/chapter33/33images/33-09.gif 
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In the human, induction of decidualization does not require the presence of the blastocyst; 
it commences in the secretory phase of every menstrual cycle and continues if pregnancy 
occurs.  The menstrual cycle is regulated by the steroid hormones estrogen (E) and progesterone 
(P). The human endometrium first undergoes an E-dominated proliferative phase followed by a 
P-dominated secretory phase [8] during which decidualization of endometrial stromal cells, 
termed predecidualization, occurs independent of conception. If there is no conception, the 
circulating P levels go down in the late secretory phase, leading to the shedding of the 
decidualized tissue layer, triggering menstruation. If pregnancy occurs, decidualization 
progresses further and spreads through the endometrium, helping trophoblast invasion and 
placenta formation [9].  
Impaired decidualization is associated with endometrial and reproductive diseases and 
dysfunctions, such as menstrual disorders, endometriosis, infertility and early pregnancy loss [7, 
10]. Therefore, a better understanding of the decidualization process will give valuable 
information to address the underlying deficiencies in some of these endometrial disorders. 
 
Estrogen and progesterone receptors and their known functions during decidualization 
E and P act, at least in part, through their nuclear receptors. These receptors belong to the 
family of ligand activated transcription factors [11]. Hormone binding causes a conformational 
change in the receptor, which triggers dimerization and DNA binding of the receptor 
accompanied by recruitment of co-regulators and associated chromosome remodeling 
complexes, leading to modulation of gene expression [11, 12]. Two receptor subtypes have been 
identified for estrogen: estrogen receptor alpha (ESR1) and estrogen receptor beta (ESR2) [13]. 
For progesterone, there are two receptor isoforms: progesterone receptor A (PRA) and 
progesterone receptor B (PRB) [14]. Various gene knockout mouse models have provided 
valuable information to understand the roles of these steroid receptors and their downstream 
targets in decidualization. For example, female mice lacking progesterone receptor A or its 
downstream target Hoxa10 are both defective in decidualization and are infertile [15-17]. On the 
other hand, the progesterone receptor B null mouse is fertile with normal decidualization 
response [18]. Estrogen receptor alpha knock out female mouse is infertile and defective in 
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decidualization (unpublished data). Estrogen receptor beta null mouse, which is subfertile, is 
reported to retain normal uterine functions including decidualization and can support normal 
pregnancy [19]. The steroid receptor coregulators play critical roles in regulating stromal 
differentiation as well. For example, the steroid receptor co-activator-1 null and Repressor of 
Estrogen Activity (REA) homozygous mutant females exhibit defects in decidualization [20, 21]. 
These in vivo data support the importance of steroid hormone receptors, PRA and ESR1 in 
particular, in regulation of decidualization process. However, the molecular mechanisms 
downstream of these receptors are still not well understood. 
 
An in vitro system to study differentiation of human endometrial stromal cells 
In order to study the molecular pathways underlying decidualization in human, an in vitro 
system using primary cultures of proliferative phase human endometrial stromal cells (HESCs) 
are used. These cells are isolated from endometrial biopsies of 18-35 years old women 
volunteers. Stromal cells are isolated by enzymatic digestion and placed in culture media 
containing serum. It is shown that these primary cultures retain their biological characteristics for 
at least ten passages and exhibit a decidualization phenotype that is very similar to endometrial 
stroma in vivo at both biochemical and morphological levels [22, 23]. Addition of a 
differentiation cocktail composed of E, P, and a cyclic AMP analog 8-Br-cAMP triggers 
differentiation of HESCs [24-26].  The fibroblastic stromal cells undergo a distinct 
morphological change as they are transformed into larger, and round decidual cells (Figure 2a). 
This transformation in the cellular architecture is accompanied by a dramatic rise in the 
expression of known biomarkers of decidualization (Figure 2b). A number of biochemical 
markers, such as prolactin (PRL) and insulin-like growth factor binding protein 1 (IGFBP1), 
have been widely used to monitor the progress of the decidualization program in vitro [22, 27].  
Use of this in vitro system to study human decidualization has many advantages. It is 
possible to manipulate the treatment conditions, such as addition or removal of steroid hormones, 
morphogens, second messengers or other regulatory molecules. SiRNA-mediated strategies can 
be used easily to alter specific gene expression to conduct functional analysis. This in vitro 
system has some limitations too. It lacks the signaling events contributed by the epithelium and 
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the implanting blastocyst. Overall, it is a very useful system to study human stromal cell 
differentiation.  
A. 
       
B. 
  
Figure 1.2: In vitro differentiation of HESC 
HESC were grown in 2% charcoal-stripped serum for 2 days. Cells were then treated 
with the differentiation cocktail containing 0.5mM 8-bromo-cAMP, 1uM P and 10nM E 
for 0-6 days.  
A. HESCs were seeded on 4-well chamber slides and subjected to in vitro differentiation 
for 6 days. DAPI (blue) and Phalloidin (green) staining of HESCs are shown. Day 0 and 
day 6 designates the time point prior to and 6 days following differentiation cocktail 
addition, respectively. 
B. HESCs were harvested at different time points following differentiation cocktail 
treatment. Total RNA was isolated and cDNAs were prepared. cDNAs were subjected to 
real-time PCR using gene specific primers for PRL and IGFBP1. Day 0 designates the 
time point prior to differentiation cocktail addition. PCR data are normalized to 36B4 
mRNA levels. Relative fold changes were normalized with respect to Day 0.  
 
0
200
400
600
day 0 day 2 day 4 day 6
PRL 
0
2000
4000
6000
8000
day 0 day 2 day 4 day 6
IGFBP1 
Day 0 Day 6 
5 
 
Roles of E and P and their receptors during HESC decidualization 
The ovarian steroids E and P are the main regulators of the decidualization process. These 
hormones act through their nuclear receptors. Estrogen receptor subtypes, ESR1 and ESR2 are 
expressed in the uterine stroma.  ESR1 is the dominant subtype. Its expression is high during 
proliferative phase and it continues during early secretory phase. By late secretory phase, the 
ESR1 expression is very much reduced. The ESR2 expression, on the other hand, is relatively 
low at all stages of the menstrual cycle. Its highest expression is observed in late secretory phase 
[28, 29]. Development of global Esr1-null mice in the Chambon laboratory and conditional Esr1 
null mice in our laboratory revealed that decidualization fails to occur in the absence of ESR1 
(unpublished data). A recent study using human endometrial stromal cells showed that 
knockdown of the estrogen receptor coregulator REA, repressor of estrogen receptor activity, 
enhanced the differentiation of HESC, as shown by the increased expressions of biomarkers of 
decidualization [30]. Although these findings suggest that ESR1 plays an essential role during 
decidualization; its role in human decidualization needs to be established. In order to achieve a 
better understanding of the E-regulated pathways underlying this important physiological 
process, it is necessary to identify gene networks that operate under the control of ESR1. 
Therefore, one of the major aims of my project is to analyze the gene networks controlled by 
ESR1 during human stromal cell differentiation. 
The requirement of progesterone receptor for decidualization has been confirmed by many 
studies including the PRA knockout mouse model, which is impaired in decidualization [31]. In 
vitro studies in human stromal cells confirmed the essential role of progesterone receptor in 
human decidualization [22]. Both isoforms of the progesterone receptor, PRA and PRB, are 
expressed in the stromal cells. The relative levels of the isoforms change during the menstrual 
cycle. During the early proliferative stage, PRB level is very low, while PRA levels are high. 
During the peri-ovulatory period, expression of both isoforms increase, and the levels of PRB 
becomes comparable to PRA levels. By late secretory phase, PRB levels decline [32, 33]. Some 
endometrial disorders show aberrant expression and relative ratios of PRA and PRB. For 
example, it was reported that the PRA:PRB ratio was abnormal in endometrial cancer [34, 35] 
and endometriosis [36] , underlining the importance of distinguishing between the roles of these 
isoforms. Although, the molecular pathways via which the progesterone receptors exert their 
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effects during decidualization have been addressed in some studies [37-39], we are still far away 
from understanding the downstream signaling mechanisms of each isoform during 
decidualization in the human. A central aim of my project is to analyze the gene networks 
controlled by PRA and PRB during human endometrial differentiation. A better understanding of 
these gene networks will help identify the mechanisms underlying
 
the normal uterine function 
and abnormalities in endometrial disorders and offer potential new
 
targets for therapeutic studies.  
 
Role of cAMP-dependent signaling during decidualization 
Numerous previous studies have documented that cAMP-induced signaling pathways are 
important in decidualization [22, 40, 41]. P alone or in combination with E is a very weak 
inducer of in vitro decidualization of HESCs [42]. Peptide hormones, such as LH/hCG, CRH, 
and relaxin, and prostanoids, such as PGE2, contribute to decidual transformation in vitro by 
binding to their G protein coupled receptors and increasing intracellular cAMP levels [43-46]. 
Studies have shown that human endometrial stromal cells express the receptors of these 
hormones [47-49]. Studies have shown that the level of intracellular cAMP is increased in 
stromal cells during decidualization in vivo [50, 51] However, how intracellular cAMP levels are 
regulated by these hormones during decidualization is not well understood.  Cyclic AMP is an 
important second messenger molecule which is generated upon binding of a ligand to its G-
protein coupled receptor (GPCR). Ligand binding induces a conformational change, leading to 
the release of the G alpha subunit from the trimeric G alpha-beta-gamma complex. G alpha 
subunit regulates the activity of adenylyl cyclase enzyme which produces cAMP from ATP [52]. 
Three major targets of cAMP signaling are protein kinase A (PKA), GTP-exchange protein 
(EPAC) and the cyclic nucleotide gated ion channels [53], with PKA being the predominant 
downstream target molecule [54]. In its inactive state, PKA is composed of two regulatory and 
two catalytic subunits. When two cAMP molecules bind to each regulatory subunit, a 
conformational change takes place along with the release of catalytic subunits from the 
regulatory subunits. The free and active catalytic subunits are able to phosphorylate target 
molecules in the cytoplasm as well as in the nucleus [54]. Several proteins have been identified 
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as substrates of PKA, including transcription factors (CREB, CREM, and ATF-1), metabolic 
enzymes and cytoskeletal elements [53, 55].  
Although cAMP analogs are widely used during in vitro decidualization of HESCs, the 
molecular targets of this signaling during this differentiation process are mostly unknown. It is 
conceivable that PKA, upon activation by cAMP, phosphorylates downstream regulatory 
molecules that play important roles in decidualization. Post-translational modification via 
phosphorylation is an important and well-studied mechanism of regulation. Therefore, 
identification of targets of phosphorylation by PKA during HSC decidualization is necessary to 
understand the mechanisms by which cAMP signaling impacts on this process. Hence, we 
investigated the role of cAMP signaling during decidualization process by identifying the 
phosphorylated targets of cAMP-activated PKA and evaluating their functions during this 
process. 
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CHAPTER II 
ROLE OF ESR1 AND cAMP DURING HUMAN ENDOMETRIAL STROMAL CELL 
DIFFERENTIATION 
ABSTRACT 
The differentiation of endometrial stromal cells, known as decidualization, is a 
prerequisite for a successful pregnancy. Estrogen and progesterone, whose actions are mediated 
by their intracellular receptors, are critical regulators of this differentiation process. The goal of 
this study is to determine the role of estrogen receptor alpha (ESR1) in human endometrial 
stromal cell (HESC) differentiation by exploring the mechanisms underlying its functions. Using 
a well-established in vitro differentiation model of primary cultures of HESC, we showed that 
ESR1 was required for HESC differentiation. Gene expression profiling experiments indicated 
that ESR1 regulated HESC differentiation in two ways: (i) by suppressing cell proliferation; (ii) 
by promoting differentiation through regulating the expression of critical players of HESC 
differentiation including PGR, FOXO1 and WNT4. Interestingly, expressions of these targets 
were dependent on the presence of 8-Br-cAMP, suggesting a link between cAMP and ESR1 
signaling. Using a proteomic approach, we identified MED1, a subunit of the Mediator 
coactivator complex, as a target of PKA in differentiating HESC.  
We found that MED1 interacted with ESR1 in HESC and silencing MED1 expression 
severely impaired stromal differentiation. In the presence of 8-Br-cAMP, the interaction between 
ESR1 and MED1 was increased which coincided with the increased recruitment of MED1 to the 
ESR1 binding regions of WNT4 gene and increased WNT4 expression. We conclude that ESR1 
plays a critical role in HESC differentiation by suppressing proliferation and inducing the 
expression of critical regulators. cAMP signaling modulates transcriptional activity of ESR1 by 
phosphorylating ESR1 coactivator MED1. 
INTRODUCTION 
Decidualization is a complex transformation process by which the endometrial tissue 
becomes competent to promote embryo-uterine interactions which is essential for a successful 
embryo implantation and maintenance of pregnancy [1-3]. The human endometrium first 
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undergoes an E-dominated proliferative phase followed by a P-dominated secretory phase [4] 
during which decidualization of endometrial stromal cells, termed predecidualization, occurs 
independent of conception. If there is no conception, the circulating P levels go down in the late 
secretory phase, leading to the shedding of the decidualized tissue layer, triggering menstruation. 
If pregnancy occurs, decidualization progresses further and spreads through the endometrium, 
helping trophoblast invasion and placenta formation [5]. Impaired decidualization is associated 
with endometrial and reproductive diseases and dysfunctions, such as menstrual disorders, 
endometriosis, infertility and early pregnancy loss [6, 7]. Therefore, a better understanding of the 
decidualization process will give valuable information to address the underlying deficiencies in 
some of the endometrial disorders. 
E and P act mainly through their nuclear receptors. Two receptor subtypes have been 
identified for estrogen: estrogen receptor alpha (ESR1) and estrogen receptor beta (ESR2) [8]. 
Estrogen receptor alpha knock out female mouse is infertile and defective in decidualization 
(unpublished data). Estrogen receptor beta null mouse, which is subfertile due to ovarian defects, 
is reported to retain normal uterine functions including decidualization and can support normal 
pregnancy [9].  Additionally, the steroid receptor coactivator-1 null females exhibit defects in 
decidualization [10]. These in vivo data support the importance of ESR1 in regulation of 
decidualization process. However, the molecular mechanisms downstream of it are still not well 
understood.  
In order to study the molecular pathways underlying decidualization in human, an in vitro 
system using primary cultures of proliferative phase HESC are used. It is shown that these 
primary cultures retain their biological characteristics in early passages and exhibit a 
decidualization phenotype that is very similar to endometrial stroma in vivo at both biochemical 
and morphological levels [11, 12]. Addition of a differentiation cocktail composed of E, P, and a 
cyclic AMP analog 8-Br-cAMP triggers differentiation of HESCs [13-15].  The fibroblastic 
stromal cells undergo a distinct morphological change as they are transformed into larger, and 
round decidual cells. This transformation in the cellular architecture is accompanied by a 
dramatic rise in the expression of known biomarkers of decidualization. A number of 
biochemical markers, such as prolactin (PRL) and insulin-like growth factor binding protein 1 
(IGFBP1), have been widely used to monitor the progress of the decidualization program in vitro 
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[11, 16]. Numerous previous studies have documented that cAMP-induced signaling pathways 
are important in decidualization [11, 17, 18]. P alone or in combination with E is a very weak 
inducer of in vitro decidualization of HESCs [19]. It has also been reported that the intracellular 
cAMP levels were increased in stromal cells during decidualization in vivo [20, 21]. Cyclic AMP 
is an important second messenger with PKA being its predominant downstream target molecule 
[22]. Several proteins have been identified as substrates of PKA, including transcription factors 
(CREB, CREM and ATF-1), metabolic enzymes and cytoskeletal elements [23, 24]. Although 
cAMP analogs are widely used during in vitro decidualization of HESCs, the molecular targets 
of this signaling during the differentiation process are mostly unknown.  
In order to achieve a better understanding of the E-regulated pathways underlying this 
human stromal cell differentiation, we identified gene networks that operate under the control of 
ESR1. This study aimed to address the role of cAMP signaling as well. 
 
MATERIALS AND METHODS 
Cell Line and Cell Culture 
The primary human endometrial stromal cells (HESC) were provided by Dr. Robert Taylor of 
Emory University Medical School. HESC were isolated from biopsies collected from 
proliferative stage endometrium of normal cycling women with no sign of uterine abnormality 
and with the volunteer’s informed consent.  These cells were cultured in DMEM/F-12 medium 
(Invitrogen) supplemented with 5% (v/v) fetal bovine serum (Hyclone), 50µg/ml penicillin and 
50µg/ml streptomycin (Invitrogen). HESC of passage number nine or earlier were used in this 
study. For in vitro differentiation, the cells were treated with differentiation cocktail composed of 
0.5mM 8-bromo-adenosine-3’,5’-cyclic monophosphate (8-Br-cAMP) (Sigma), 1µM 
progesterone (Sigma) and 10nM 17-β-estradiol (Sigma) in DMEM/F-12 medium (Invitrogen) 
supplemented with 2% (v/v) charcoal dextran stripped fetal bovine serum. The medium was 
refreshed in every 48h. 
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siRNA transfection 
HESC were transfected with siRNA targeting ESR1 (Ambion), PGR (Dharmacon), PRKACA 
(Dharmacon), MED1 (Dharmacon) or non-targeting control siRNA (Ambion/Dharmacon) 
following manufacturer’s protocol (SilentFect, Bio-Rad Laboratories). To downregulate 
expressions of ESR1, PGR and MED1, a final siRNA concentration of 20nM and to 
downregulate PRKACA, a final concentration of 40nM siRNA were used. Briefly, proper 
dilution of siRNA was mixed together with SilentFect (5µl per reaction) to transfect the cells. At 
48h following siRNA treatment, medium was removed, cells were washed with PBS and cells 
were treated with differentiation cocktail for time periods as indicated in the figure legends.  
Double thymidine block 
Double thymidine block method was used with minor modifications to synchronize HESC [25]. 
Briefly, cells were seeded in 2-well chamber slides. Cells were grown to 60% confluency, and 
then cells were washed with 1xPBS and incubated in growth medium with 2mM thymidine for 
12-14h. Thymidine block was released by removing thymidine containing medium and washing 
cells with 1xPBS three times. Cells were incubated in fresh growth medium for 12h. The siRNA 
was added to the cells during the release and the transfection was carried out for 24h to 36h 
concurrent with the second thymidine block which was started by adding thymidine directly to 
siRNA containing medium to a final concentration of 2nM. Thymidine and siRNA treatment was 
removed and cells were washed with 1xPBS three times; then cells were incubated in 
differentiation cocktail containing medium. To monitor cell proliferation, we added BrdU to the 
medium during the differentiation cocktail treatment. 
Immunocytochemistry 
HESC were fixed in 4% formalin solution (Sigma) at room temperature for 10 min, followed 
PBS washes. The cells were permeabilized by 0.1% Triton X-100 in PBS for 15 min and non-
specific binding of antibodies was blocked with 10% normal donkey serum at room temperature 
for 1 h. Alexa Fluor 488 phalloidin (Invitrogen), which selectively recognizes F-actin, was used 
at a dilution of 1:50 and cells were incubated with the antibody for 20 min at room temperature. 
DAPI (1µg/ml) was used as counter staining. 
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Microarray sample preparation and data analysis 
HESC were transfected with siRNA targeting ESR1 (Ambion) or non-targeting control siRNA 
(Ambion) as explained above. Total RNA was isolated by Trizol reagent (Invitrogen, CA) and 
further purified using RNeasy columns (Qiagen) following manufacturer’s instructions. RNA 
samples were processed at the Biotechnology Center of the University of Illinois at Urbana-
Champaign. RNA integrity was verified using Agilent 2100 Bioanalyzer. Each RNA sample was 
processed to generate labeled cRNA following established protocols for hybridization to the 
GeneChip Human Gene 1.0 ST arrays, which offer whole-transcript coverage by representing 
each of the 28,869 genes [26]. The resulting data files were analyzed by Affymetrix GeneChip 
Expression Console software using RMA algorithm. Genes with a minimum of 1.2-fold-change 
in the same direction in all three independent microarrays were considered as differentially 
regulated genes. Canonical pathways analysis identified the pathways from the Ingenuity 
Pathways Analysis library of canonical pathways (Ingenuity Systems) [27] which were most 
significantly enriched in the data set. Subsets of the related genes that were assigned to a 
canonical pathway were considered for further analysis. 
RNA Isolation and Real-time PCR Analysis 
Total RNA was extracted from cultured HESC using Trizol (Invitrogen) according to 
manufacturer’s instructions. Total RNA was subjected to cDNA conversion using Stratagene 
cDNA conversion kit, following manufacturer’s instructions. cDNA were subjected to 
quantitative PCR analysis using gene specific primers. 36B4 was used as the internal control. For 
a given sample, threshold cycle (Ct) and (standard deviation) SD was calculated from individual 
Ct values from three technical replicates. Normalized mean Ct (ΔCt ) was calculated by 
subtracting mean Ct of 36B4 from mean Ct of a target gene for control sample. ΔΔCt was then 
calculated for each gene as a difference in ΔCt values between control and sample. Fold change 
in gene expression was then computed as 2-ΔΔCt. The RNA samples were prepared from 
minimum of three separate primary cultures subjected to the same experimental treatment. The 
real time PCR results are expressed as mean ± standard deviation of three biological replicates. 
Statistical significance of the data was determined using student t-test. A p-value of <0.05 was 
considered significant. 
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Adenovirus Transduction 
HESC were transduced with the adenovirus expressing Flag tagged ESR1 for 24h before the 
treatments. The flag-tagged-ESR1 expressing adenovirus was kindly provided by laboratory of 
Prof. Benita Katzenellenbogen of University of Illinois at Urbana-Champaign. 
Western Blot Analysis 
Primary HESCs were subjected to different treatments as indicated in the figure legends for 
indicated periods of time. Whole cell extracts were prepared and equal amounts of proteins were 
analyzed by SDS-PAGE, transferred to PVDF membrane and the specific proteins were detected 
by Western blotting using the antibody against Calnexin (Santa Cruz), ESR1 and antibodies 
against phospho-ESR1: Ser118 (Phospho-Estrogen Receptor α Antibody Sampler Kit, Cell 
Signaling, #9924). Antibody recognizing PGR was kindly provided by Prof. Dean Edwards of 
Baylor College of Medicine. Phospho-PKA Substrate (RRXS*/T*) (100G7E) Rabbit mAb 
#9624 was purchased from Cell Signaling. PKA is a member of  AGC kinase subfamily which 
recognizes substrates by arginine at position -3 relative to the phosphorylated serine or threonine 
[28].  The antibody was raised against KLH-coupled synthetic peptides, known as phospho-PKA 
substrate (RRXS/T). It can efficiently recognize proteins containing a phosphorylated serine or 
threonine residue with arginine at the -3 and -2 positions whereas it does not recognize the 
nonphosphorylated form [29]. Two antibodies against MED1 were used (A300-793A, Bethyl 
Laboratories; sc8998, Santa Cruz Biotechnology).  
Immunoprecipitation and Silver Staining 
Primary HESCs were subjected to decidualization in vitro in the presence of differentiation 
cocktail and the cells were harvested at different times after cocktail addition. Whole cell 
extracts were prepared and equal amounts of proteins were used for immunoprecipitation (IP). IP 
was performed using Direct IP Kit following manufacturer’s instructions (Thermo Scientific). 
Immune complexes eluted were separated by SDS-PAGE. The gel was silver stained using Silver 
Quest Staining kit (Invitrogen) following manufacturer’s instructions. Specific bands cut from 
the gel were submitted to Proteomics Center of UIUC for LC/MS analysis for protein 
identification. 
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Chromatin immunoprecipitation 
ChIP assays were performed using the EZ-ChIP kit (Millipore) according to the manufacturer's 
instructions with minor modifications. HESC were seeded on 150mm dishes. After cells were 
attached, medium was switched to 2% (v/v) charcoal dextran stripped fetal bovine serum 
containing medium and transduced with adenovirus carrying flag-tagged ESR1 for 24h.  Next 
day, cells were either treated with E+P or E+P+8-Br-cAMP for 30 min. Then, cells were fixed 
with 1% formaldehyde for 10 min and excess formaldehyde was quenched with 0.25 M glycine 
for 5 min. Cells were then washed twice with cold PBS, scraped and collected in PBS containing 
protease inhibitors in a canonical tube and centrifuged. Cell pellet was resuspended in lysis 
buffer containing protease inhibitors for 15 min to lyse the cells. Next, chromatin was sonicated 
in four 15-s pulses with cooling between pulses (Fisher Scientiﬁc model 100 Sonic 
Dismembrator). One percent of the cell lysate was used for input control, and the rest was 
incubated with anti-flag M2 affinity gel (Sigma, A2220) to immunoprecipitate flag-ESR1 or 
anti-MED1 antibody (Santa Cruz, sc-8998) overnight at 4
0
C to isolate the immune complexes. 
Normal mouse IgG (Santa Cruz, sc-2027) immunoprecipitation served as a negative control. 
Complexes were washed with low salt, high salt, LiCl buffers and twice with TE buffers, eluted 
from the beads and heated at 65°C for 6 hours to reverse the cross-linking. After digestion with 
RNAase A and proteinase K, DNA fragments were purified using QIAquick PCR purification kit 
(Qiagen). For ChIP, real-time quantitative PCR (Q-PCR) primers were designed to amplify the 
potential ESR1 binding element (ERE) in the regulatory regions of WNT4 gene and also a primer 
pair flanking an ERE free sequence was used as a negative control. The resulting signals were 
normalized to input DNA and relative fold enrichment was calculated as the enrichment in 
experimental samples over that of negative control ChIP.  
 
RESULTS 
ESR1 is required for HESC differentiation  
In vivo studies have shown that ESR1 is expressed in human endometrial stroma during the 
proliferative and secretory phases of the menstrual cycle [30]. We monitored ESR1 expression in 
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primary cultures of HESC isolated from endometrial biopsies collected from early proliferative 
phase uterus. We detected ESR1 mRNA and ESR1 protein in the proliferative stage stromal cells 
prior to the addition of a differentiation cocktail containing E, P, and 8-Br-cAMP. Addition of 
the differentiation cocktail, which induced decidualization of HESC, led to a marked increase in 
ESR1 mRNA and protein levels within 24 h (Fig. 2.1, A and B). It is known that the estrogen 
receptor is phosphorylated at several residues and its phosphorylation status affects its 
transcriptional activity. It is generally accepted that phosphorylation at Ser118 enhances 
transcriptional activity of the receptor by increasing the recruitment of coactivators [31].  
Therefore, we analyzed the Ser118 phosphorylation of ESR1 in differentiating HESC compared 
to undifferentiated cells. For easy isolation of ESR1 and assessment of its phosphorylation state, 
we enhanced the level of ESR1 in HESC by expressing a flag-tagged human ESR1 in these cells 
via an adenoviral vector. 24h following viral transduction, HESC were treated with or without 
the differentiation cocktail for 6 h. Ser-118 phosphorylation was very low in the undifferentiated 
cells and significantly enhanced upon addition of the differentiation cocktail (Fig. 2.1C). The 
enhanced expression of ESR1 and a distinct change in its phosphorylation during the initiation of 
the decidualization program hinted at a potential role of this ligand-inducible transcription factor 
in HESC differentiation. To test this possibility, ESR1 expression was silenced in HESC by 
administering siRNA specifically targeting ESR1 mRNA and then we examined the effect of this 
down regulation on the differentiation process. Analysis of mRNAs corresponding to PRL and 
IGFBP1, well-known biochemical markers of decidualization, by real-time qPCR revealed a 
significant decrease in the expression of these genes (Fig. 2.1D). These gene expression changes, 
indicating a lack of stromal differentiation in the absence of ESR1, were also consistent with the 
lack of morphological changes that one associated with decidualization process (Fig. 2.1E). 
HESC displayed the round epitheloid characteristics of the differentiated cells in the presence of 
ESR1, but failed to acquire this morphology and remained fibroblastic in the absence of this 
receptor. Collectively, these results supported our view that ESR1 plays a critical regulatory role 
in the in vitro differentiation of HESC.  
Cell cycle progression is suppressed downstream of ESR1 during HESC differentiation 
To identify the ESR1-regulated downstream pathways associated with HESC differentiation, we 
used oligonucleotide microarrays. Our approach involved comparing the gene expression 
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profiles of three different clinical samples of proliferative phase HESC transfected with siRNA 
targeted to ES1 mRNA or non-targeting control siRNA as described in materials and methods 
section. When the gene expression profiles of control and ESR1-depleted samples of three 
independent sample sets were compared, 194 genes were found to be commonly down-regulated 
while 318 genes were up-regulated. Genes with altered regulation were classified according to 
their known biological functions and the canonical pathways using Ingenuity Pathway Analysis 
(Table 2.1). A prominent category of genes whose expression was altered in the absence of 
ESR1 was cell cycle and growth regulatory pathways. The expressions of the cycle cycle-
regulatory molecules, including CCNE2, CCNA2, CDC20, CDK1, CDK2, PLK4 and SKP2 were 
upregulated in ESR1-depleted HESC. We also noted that important suppressors of cell 
proliferation, including CDKN1C (cyclin dependent kinase inhibitor 1C or p57) and GAS1 
(growth arrest specific 1) were downregulated in the absence of ESR1 (Table 2.2). These results 
indicated that ESR1 played cell cycle regulatory functions during HESC differentiation. It is 
generally observed that the cell cycle exit is a pre-requisite for differentiation [32]. We and 
others have observed that HESC, which showed robust proliferation in the growth medium, 
ceased proliferation under differentiation conditions (Fig. 2.2A); suggesting that the exit from the 
cell cycle is a key step in HESC differentiation and ESR1 may be involved in this process. To 
validate the altered expression of the microarray-derived cell cycle regulatory genes downstream 
of ESR1, we performed real-time PCR analysis. We confirmed that the expressions of a subset of 
cell cycle related genes identified in the microarray studies including CCNE2, CCNA2, CDC20 
and CDK1, were upregulated in ESR1-depleted HESC, while that of CDKN1C and GAS1 was 
downregulated in the absence of this receptor. We also found that the expression levels of E2F1 
and E2F2 were upregulated in HESC when ESR1 was down-regulated, whereas E2F3 levels 
remained unchanged (Fig. 2.2B). Since the expression of genes which are critical regulators of 
the G1-S transition was altered in the absence of ESR1, we considered the possibility that ESR1 
suppresses this critical step of the cell cycle during HESC differentiation. Next, we investigated 
whether the loss of ESR1 actually resulted in the stimulation of cell cycle progression of HESC 
under the differentiation conditions as suggested by the gene expression changes shown in Fig. 
2.2B. To test this possibility, we first synchronized the HESC at the G1/S boundary of the cell 
cycle, using double thymidine block method [25]. Our results indicated a significant increase in 
BrdU incorporation in HESC depleted of ESR1 compared to the control samples (Fig. 2.2C). 
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Collectively, these results suggest that ESR1 suppresses the cell cycle at G1/S phase during 
differentiation of HESC.  
Well-known regulators of decidualization are controlled by ESR1 
Among the many genes whose expression was down-regulated in the gene expression 
profile in response to the attenuation of ESR1 expression, we found three important known 
regulators of HESC differentiation: progesterone receptor (PGR), Forkhead Box Protein O1 
(FOXO1) and wingless-type MMTV integration site family, member 4 (WNT4) [33-35]. As 
shown in Fig. 2.3A, expressions of both FOXO1 and WNT4 mRNAs were markedly 
downregulated at 24h and 72 h of differentiation when ESR1 expression was silenced. We did 
not detect a significant down-regulation of PGR mRNA at 24h of differentiation. However, PGR 
mRNA levels were markedly down regulated in ESR1-depleted cells at 72h of differentiation 
(Fig. 2.3A). These results are consistent with a role of ESR1 as a regulator of HESC 
differentiation. Since the PGR levels did not change significantly while that of FOXO1 and 
WNT4 levels was markedly diminished in ESR1-depleted HESC at 24 h of differentiation 
cocktail treatment, we hypothesized that FOXO1 and WNT4 are regulated by ESR1 in a PGR 
independent manner. Real-time PCR analysis confirmed that FOXO1 expression was 
downregulated specifically by siRNA mediated silencing of ESR1 but not PGR (Fig. 2.3B). 
Similarly, FOXO1 protein level was markedly reduced in ESR1-depleted HESC while it did not 
change upon PGR knock down (Fig 2.3C), suggesting that FOXO1 was a downstream target of 
ESR1 during decidualization of HESC and its regulation by ESR1 occurred in a PGR-
independent manner. It is noteworthy that FOXO1 might be the key downstream molecule under 
ESR1 which suppresses stromal cell proliferation during differentiation, as FOXO1 was shown 
to inhibit G1-S transition of HESC under differentiation conditions [35].  
Expression of ESR1 target genes in differentiating HESC requires addition of cAMP 
After identifying FOXO1, WNT4 and PGR as downstream targets of ESR1, we monitored their 
expressions in response to E treatment. To our surprise, we did not detect significant up-
regulation of these genes when HESC were treated with estrogen alone or estrogen plus 
progesterone while the addition of cAMP to the cocktail led to a robust increase in their 
expression (Fig. 2.3D). We should note that the expression of these genes is ESR1 dependent 
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since their expression is impaired when the receptor is silenced in the presence of cAMP 
(Figures 2.3A and 2.3B), suggesting that there might be a link between cAMP and ESR1 
signaling to regulate the expression of these genes.  
PKA signaling is required for in vitro differentiation of HESC 
The cyclic AMP analogue, 8-Br- cAMP, used for in vitro differentiation of HESC can 
activate both PKA and EPAC [36]. Gellersen and Brosens reported that treatment of 
undifferentiated HESC with a novel EPAC-specific cAMP analogue -8-p CPT-2_-O-methyl-
cAMP- [37], did not  induce a decidual phenotype [11], suggesting that PKA is the critical target 
of cAMP for induction of differentiation of HESC. In support of this, it has been reported that 
decidualization is impaired when HESC are treated with PKA inhibitor H89 [38]. However, 
there are several reports documenting that H89 has unspecific inhibitory effects on other kinases 
[39]. Therefore, we wanted to confirm that PKA is the principal target of cAMP during in vitro 
differentiation of HESCs by using a more specific tool. We used siRNA approach to knock down 
the major catalytic subunit of PKA, alpha (PRKACA), in HESC [17] and monitored the 
expression of well-known decidual markers in PRKACA-depleted cells. The cells treated with 
PRKACA-specific siRNA showed a marked impairment in expression of decidualization 
markers compared to control siRNA treatment (Fig. 2.4A). These results suggested that PKA 
signaling, when activated upon binding to cAMP, is critical for induction of HESC 
differentiation. 
MED1 is a downstream target of cAMP signaling during HESC differentiation 
It is conceivable that cAMP activates PKA and active PKA phosphorylates downstream 
regulatory molecules that play important roles in decidualization. To identify the targets of PKA-
dependent phosphorylation during decidualization, we employed a monoclonal antibody that 
specifically recognizes the phosphorylated PKA substrates. To determine the pattern of PKA-
dependent phosphorylation in response to cAMP, HESCs were untreated or treated with E+P or 
E+P+cAMP. The cells were harvested at 24h after cocktail addition. Whole cell extracts were 
prepared and equal amounts of proteins were analyzed by SDS-PAGE. The phosphorylated PKA 
target proteins were detected by Western blotting using the antibody against phospho-PKA 
substrate. A number of phosphorylated bands were already present in extracts of untreated cells. 
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We did not observe prominent changes in E+P treated sample. Strikingly, several additional 
bands appeared in the sample treated with E+P+cAMP (Fig. 2.5A). To further ascertain that the 
phosphorylated bands were generated by actions of PKA, we treated the cultures with H89, a 
PKA inhibitor. In the presence of H89, the majority of the phosphorylated bands were reduced in 
intensity or absent, confirming that they represented PKA targets (Fig. 2.5B) and we were able to 
get similar results when we silenced the expression of the catalytic subunit of PKA with siRNA 
and (data not shown). These results confirmed that the antibody could specifically detect 
phosphorylated targets of PKA. To identify these phosphorylated targets of PKA in 
differentiating HESC, whole cell protein extracts were prepared from HESCs treated with or 
without differentiation cocktail for 24 h. The phosphorylated proteins were immunoprecipitated 
(IP) using the phospho-PKA substrate antibody. The immune complexes were isolated and 
analyzed by SDS PAGE and the banding pattern was visualized by silver staining the gel (Fig. 
2.5C). The banding patterns of PKA-phosphorylated polypeptides in untreated and 
differentiation cocktail-treated were compared and individual bands with increased intensity 
were cut out and subjected to analysis by Mass Spectrometry (LC/MS). Among potential targets 
including vimentin, non-muscle myosin 9, skeletal tropomyosin and MED1 (Fig. 2.5D), we 
decided to focus on MED1 which is a subunit of the Mediator complex that forms a bridge 
between the transcription factors and the general transcription machinery [40] and by in vitro 
studies, it has been shown to be a target of several kinases including MAPK, PKC and PKA [41]. 
To further confirm that MED1 is phosphorylated by PKA in differentiating HESC, we 
immunoprecipitated MED1 with a MED1 specific antibody from whole cell extracts of either 
untreated or differentiation cocktail treated HESC.  We then performed a western blot analysis 
with phospho-PKA substrate antibody. In the extracts derived from untreated cells, we detected a 
faint band corresponding to the molecular size of MED1 while in differentiation cocktail treated 
samples the intensity was increased considerably (Fig. 2.5E). 
MED1 interacts with ESR1 and regulates target gene expression in HESC 
MED1 subunit has the LXXLL signature motif which is important for interactions with nuclear 
receptors and has been shown to physically interact with several nuclear receptors, including 
thyroid receptor, vitamin D receptor, ESR1 and ESR2 [42-45]. In order to assess the possible 
interaction between MED1 and ESR1 in differentiating HESC, we performed co-
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immunoprecipitation experiments. Immunoprecipitation was carried out on whole-cell extracts of 
differentiating HESC transduced with adenovirus expressing flag tagged ESR1 using anti-MED1 
antibody. We detected ESR1 in the IP performed with the MED1 antibody (Fig. 2.6A), 
suggesting that MED1 and ESR1 interact in differentiating HESC. In parallel experiments, 
similarly prepared whole-cell extracts were immunoprecipitated with anti-flag M2 antibody 
coupled to beads, which recognize the exogenously expressed flag-tagged ESR1. As shown in 
Fig. 2.6B, MED1 co-precipitated with flag-ESR1 and the amount of MED1 that interacts with 
ESR1 was increased modestly in the presence of the differentiation cocktail compared to 
untreated sample. This increase was more prominent when MED1 was immunoprecipitated and 
the levels of co-precipitated ESR1 were monitored in E+P versus E+P+cAMP treated samples 
(Fig 2.6C), which coincided with the expression data of ESR1 target genes in the presence of 
E+P+cAMP compared to E+P.  
MED1 is required for HESC differentiation: 
As we documented that ESR1 was required for stromal differentiation and MED1 was a 
coactivator of ESR1 and a target of cAMP signaling, we investigated whether MED1 had a 
functional role during in vitro differentiation of HESCs. The silencing of MED1 expression 
resulted in a clear impairment in expression of the decidualization markers (Fig 2.7A) and a lack 
of morphological changes that associated with the differentiation process (Fig. 2.7B) suggesting 
that MED1 was required during in vitro differentiation of HESC. These data indicated that 
MED1 was a critical mediator of cAMP regulation of HESC decidualization and controlled the 
expression of a subset of the downstream targets of ESR1 including WNT4 during the 
differentiation process (Fig. 2.7C). To test whether ESR1 brought MED1 to a target genomic 
region, we performed chromatin immunoprecipitation (ChIP) experiments on potential estrogen 
receptor binding sites in the regulatory regions of WNT4 gene (Fig. 2.7D). These potential sites 
were recruited from available literature on ESR1 cistrome [46]. We found that MED1 was also 
recruited to these potential binding sites in the presence of cAMP+E+P while the recruitment of 
MED1 was minimal in the absence of cAMP when the cells were treated with E+P (Fig. 2.7E).  
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DISCUSSION 
In the present study, we used primary cultures of HESC to establish the requirement of 
ESR1 for decidualization in human. We combined an ESR1 knock-down approach with gene 
expression profiling analysis to identify ESR1-dependent gene pathways in differentiating 
HESC. Our microarray analysis revealed that, in differentiating HESC, ESR1 controls several 
pathways belonging to various biological categories. Prominent among those are genes that 
encode cell cycle regulatory molecules. Specifically, genes involved in cell cycle progression, 
including CCNE2, CCNA2, CDC20, CDK1, CDK2, NEK1, NEK2, SKP2 and PLK4 were up-
regulated in ESR1 depleted HESC. In contrast, genes involved in inhibition of the cell cycle, 
such as CDKN1C and GAS1, were down regulated when ESR1 was silenced. In agreement with 
these findings, we showed that stromal cell proliferation, as measured by BrdU incorporation, 
was increased in the absence of ESR1. It is remarkable that several of the cell cycle regulators 
found downstream of ESR1 in this present study were previously documented to be differentially 
expressed in secretory phase endometrium when compared to proliferative phase; as mRNA 
levels of CCNA2, CCNE2, CDC20 were reported to be decreased and mRNA levels of CDKN1C 
and GAS1 were found to be increased significantly in the secretory phase [47, 48]. However, to 
our knowledge, there had been no reports suggesting that these genes were downstream of ESR1.  
Wu et. al., using an immortalized endometrial cell line, studied the effects of various steroid 
receptor inhibitors on endometrial proliferation and showed that ICI had no inhibitory effect; in 
fact, at low levels it had a positive effect on cell proliferation [49] and our studies showed, for 
the first time, that ESR1 suppressed endometrial stromal cell proliferation and promoted their 
differentiation. These findings may be important in understanding the endometrial proliferation, 
and also should be considered when planning treatments for endometrial diseases such as 
endometriosis. Although estrogens generally induce proliferation of a variety of cells, this is one 
of the unique cases where estrogen receptor alpha suppresses cell cycle progression. The 
difference in the proliferative response may depend on the cell context, the expression levels of 
cofactors, the activities of other signaling pathways, epigenetic differences etc. For instance, 
estrogen treatment induces cell proliferation in MCF7 cells while represses proliferation of 
MDA-MB-231 cells. Previous study by Stender et al. showed that the difference in the 
proliferative response to estrogen in these two breast cancer cell lines  correlated with the 
regulation of E2F1 by estrogen receptor [50]. Additionally, Frietze et al. documented the 
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recruitment of ESR1 to the E2F1 promoter in MCF7 cells [51], suggesting that E2F1 may be a 
direct target of ESR1 and, depending on the cell context, its expression might be induced or 
repressed by ESR1.  It is of interest to note that the E2F family members, which are key 
regulators of G1-S transition, also regulate the expression of CCND3, CDC20 and CCNA2 [50, 
52]. This raised the interesting possibility that the ESR1 regulation of these cyclins and the 
cyclin-dependent kinase may be a direct consequence of ESR1 regulation of the E2Fs. Future 
chromatin immunoprecipitation experiments testing whether ESR1 directly regulates E2F1 or 
E2F2 are necessary to test this hypothesis.  
Additionally, this study supports a central role for ESR1 in regulating HESC 
differentiation. WNT4, FOXO1 and PGR, which are well known regulators of HESC 
differentiation, were induced downstream of ESR1. While the expressions of FOXO1 and WNT4 
were drastically reduced within 24 h of the differentiation reaction in the absence of ESR1, the 
level of PGR was down-regulated significantly only at later time points such as 48h and 72 h. 
Therefore, it is possible that FOXO1 and WNT4 are PGR independent downstream targets of 
ESR1. FOXO1, a member of Forkhead family of transcription factors, is involved in cell cycle 
inhibition, defense against oxidative stress, DNA repair and apoptosis [53, 54] and importantly, 
in HESC decidualization; as Takano et al. reported, HESC differentiation was impaired in 
FOXO1-depleted cells [35]. Interestingly, they showed that FOXO1 silencing promoted 
proliferation of HESC under differentiation conditions and several of the cell cycle-related genes 
reported to be regulated by FOXO1 such as CDKN1C, BUB1, NEK2 and PLK4, were also found 
to be downstream of ESR1 in our gene expression studies. This raises the possibility that some of 
the inhibitory effects of ESR1 on cell cycle progression of HESC could be mediated by FOXO1.  
We observed that the expressions of ESR1 targets that we identified in this study were 
dependent on the presence of cAMP, which suggested a link between cAMP signaling and ESR1 
signaling. We hypothesized that cAMP might be acting through PKA to phosphorylate the 
estrogen receptor or some other molecules such as kinases or cofactors that could modulate the 
receptor activity. We first tested whether ESR1 was phosphorylated by PKA and failed to detect 
any phosphorylation using PKA substrates antibody (data not shown). However, it is possible 
that this antibody does not recognize all targets of PKA. Therefore it is necessary to use 
phospho-ESR1 specific antibodies to test this possibility. Additionally, the effect of PKA on the 
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receptor might be indirect; the receptor might be modified post-translationally by a PKA target. 
One candidate signaling molecule was MAPK, which is known to modulate ESR1 activity 
through direct phosphorylation of the receptor on Ser118 residue. Our preliminary analysis 
showed that the Ser118 phosphorylation of ESR1 was primarily ligand, estrogen, dependent; and 
addition of cAMP increased Ser118 phosphorylation modestly (data not shown). Further detailed 
analyses are necessary to have a better understanding of this possibility.  
Since there are several possible mechanisms through which cAMP signaling might 
modulate ESR1 activity, we decided to use an unbiased proteomic approach to identify the 
molecules which were getting phosphorylated by PKA during HESC differentiation. The 
potential targets that were detected by our preliminary experiments using mass spectrometry 
included MED1 and several cytoskeletal proteins. Among them, vimentin was previously shown 
to be phosphorylated by PKA. Phosphorylated vimentin showed decelerated filament formation 
in vivo [55]. Also, PKA-mediated phosphorylation of myofibrillar proteins was reported to alter 
the mechanical properties of myocardium [56]. We believe that phosphorylation of cytoskeletal 
elements by PKA may be important for the differentiation process as decidualization involves 
major cytoskeletal remodeling. Amongst the potential targets of PKA, we focused on the 
cofactor MED1, a subunit of the Mediator complex, which interacts with a variety of nuclear 
receptors and forms a bridge with the general transcription machinery [40, 42-45]. MED1 is a 
phospho-protein and in support of our finding, it was previously identified as an in vitro substrate 
for PKA [41]. We showed that MED1 and ESR1 interacted in HESC and with addition of 
cAMP+E+P, both were recruited to ESR1 binding sites previously identified in WNT4 
regulatory regions [46]. Previous work indicated that MAPK phosphorylation of MED1 
stimulated transcriptional coactivation activity of MED1 [57]. Belakavadi et al. showed that 
while phosphorylation of MED1 by ERK did not alter its interaction with the thyroid receptor 
(TR), it promoted its association with the Mediator complex and enhanced TR dependent 
transcription [58]. We speculate that the phosphorylation of MED1 by PKA may present a 
mechanism by which cAMP effects could be linked to gene transcription as we documented that 
the interaction between ESR1 and MED1 was increased with the addition of cAMP to E+P 
treatment. A similar mechanism between ESR1 and coactivator-associated arginine 
methyltransferase 1 (CARM1) was identified by Carascossa et al. in MCF7 cells; as they showed 
that phosphorylation of CARM1 by PKA was necessary and sufficient for its direct binding to 
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the estrogen receptor while phosphorylation of the estrogen receptor by PKA was not required 
for this interaction [59].  Therefore, further characterization of the possible functional roles of the 
PKA phosphorylation of MED1 by examining its interactions with the Mediator complex upon 
phosphorylation and consequent effects on transcriptional activity of ESR1 is necessary. It 
should also be considered that MED1 serves as a cofactor of several other nuclear receptors, 
including RAR and PPARG. Interestingly, these molecules were reported to be negative 
regulators of HESC differentiation and their transcriptional activity might also be affected by 
post translational modification of MED1 which might have important regulatory roles in 
progression of HESC differentiation [60, 61]. 
Finally, we showed that the HESC differentiation was severely impaired in MED1 
depleted cells. Interestingly, we did not observe impairment in their proliferation (data not 
shown). A similar role of MED1 in adipogenesis was reported by Ge et al. using fibroblast cells 
lacking MED1. These cells were reported to be impaired in PPARG stimulated adipogenesis 
while they could differentiate into myocytes through MyoD stimulated myogenesis [62].  
In summary, our study revealed that ESR1 had two main roles during human 
decidualization. First, it suppressed the proliferation of HESC. We hypothesize that ESR1 may 
inhibit proliferation of stromal cells by suppressing the expression of E2F1 and E2F2 and their 
downstream cell cycle regulatory factors and also through upregulation of FOXO1 as this 
molecule was previously shown to be a suppressor of HESC proliferation during differentiation 
[35]. Second, ESR1 regulated the differentiation of HESC by inducing the expression of 
important regulators of the differentiation process, namely FOXO1, WNT4 and PGR. Future 
studies will address the precise mechanisms by which ESR1 conducts these regulatory events. 
Additionally, we identified MED1 as a potential substrate of PKA and showed that it interacted 
with ESR1. Moreover, we showed that differentiation was severely impaired in MED1 depleted 
cells, suggesting that MED1, upon phosphorylation by PKA, was indeed required for 
differentiation of HESC and expression of ESR1 downstream genes which might be one of the 
signaling mechanisms cAMP employed to drive stromal differentiation together with the steroid 
hormones (Fig. 2.8). 
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Figure 2.1: ESR1 is required for HESC differentiation 
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Figure 2.1 cont.: A. HES C were either untreated or treated with differentiation cocktail. Cells 
were harvested at 24h following treatment. Total RNA was isolated and cDNAs were prepared. 
cDNAs were subjected to  real-time PCR using gene specific primers for 36B4 and ESR1. PCR 
data are normalized to 36B4 mRNA levels. Relative fold changes were normalized with respect 
to the untreated sample. Error bars represent ± standard deviation of at least three independent 
experiments. B. HESC were either untreated or treated with differentiation cocktail as indicated 
on the figure. Cells were lysed at 24h following treatment, analyzed by SDS-PAGE and 
subjected to Western Blotting using antibodies directed against ESR1 and Calnexin. Calnexin 
immunoblotting serves as a loading control. C.HESC were transfected with adenovirus 
expressing flag tagged wild type ESR1 in charcoal stripped serum containing medium for 24h. 
After viral transfection, medium was removed and HESC were either untreated or treated with 
differentiation cocktail for 3h. Cells were harvested and whole cell protein extracts were 
prepared. Equal amounts of protein of each sample were analyzed by SDS-PAGE. Western blot 
was performed using either anti-ESR1 phosphoserine (α-pS118) or anti-ESR1 antibodies. Figure 
is the representative of three independent experiments. D.HESCs were transfected with siRNA 
targeting ESR1 or scrambled siRNA (control). 48h after transfection, HESCs were treated with 
differentiation cocktail to initiate in vitro differentiation. Cells were harvested at 72h following 
differentiation cocktail treatment. Total RNA was isolated and cDNAs were prepared. cDNAs 
were subjected to  real-time PCR using gene specific primers for ESR1, PRL , IGFBP1 and 
WNT4. PCR data are normalized to 36B4 mRNA levels. Relative fold changes were normalized 
with respect to control non-targeting siRNA treatment. Figure is the representative of three 
independent experiments. E. HESCs were seeded on 4-well chamber slides and cells were 
transfected with siRNA targeting ESR1 or scrambled siRNA (control). 48h after transfection, 
HESCs were treated with differentiation cocktail to initiate in vitro differentiation.  At 96h of 
differentiation, cells were fixed and stained as explained in materials and methods. Top panel is a 
reference representing the typical morphological transformation of HESC into differentiated 
HESC. Phalloidin (green) staining of HESCs are shown. 
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Table 2.1: Ingenuity Pathway Analysis of Canonical Pathways for the ESR1 dependent 
Genes 
Genes with altered expression in ESR1 siRNA transfected cells compared to control 
siRNA transfected cells were categorized by canonical pathways using Ingenuity 
pathway analysis software (IPA).  
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Symbol Entrez Gene Name 
fold 
change 
(mean) 
AURKA Aurora  kinase A 1.6 
AURKB Aurora  kinase B 1.8 
BUB1 Budding Uninhibited By Benzimidazoles 1 1.8 
BUB1B budding uninhibited by benzimidazoles 1 homolog beta (yeast) 2.0 
CCNA2 cyclin A2 1.8 
CCND3 cyclin D3 1.3 
CCNE2 cyclin E2 1.7 
CDC20 cell division cycle 20 homolog (S. cerevisiae) 1.8 
CDK1 cyclin-dependent kinase 1 1.9 
CDK2 cyclin-dependent kinase 2 1.3 
CKS2 CDC28 protein kinase regulatory subunit 2 1.5 
E2F8 E2F transcription factor 8 1.3 
ESPL1 extra spindle pole bodies homolog 1 (S. cerevisiae) 1.4 
HSP90AA1 heat shock protein 90kDa alpha (cytosolic), class A member 1 1.3 
KIF23 kinesin family member 23 1.5 
NEK2 NIMA (never in mitosis gene a)-related kinase 2 1.8 
NUSAP1 nucleolar and spindle associated protein 1 1.8 
PLK4 polo-like kinase 4 1.9 
SKP2 S-phase kinase-associated protein 2 (p45) 1.4 
SLK STE20-like kinase 1.5 
TFDP1 transcription factor Dp-1 1.2 
 
Table 2.2: List of cell cycle related molecules downstream of ESR1 during HESC 
differentiation 
List of cell cycle related genes identified in our microarray analysis with increased 
expression in siESR1 transfected samples compared to control siRNA transfected 
samples.  
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Figure 2.2: ESR1 suppresses the proliferation of HESC during in vitro differentiation 
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Figure 2.2 cont.: 
A. Cell cycle progression is significantly reduced during in vitro differentiation. HESCs were 
seeded on 4-well chamber slides and cells were either untreated or treated with E+P+cAMP 
for 72h. Cells were fixed and subjected to immunofluroscence, using an antibody specific for 
Ki67. Positive staining for Ki67 is indicated in red and DAPI stained nuclei are shown in 
blue.  
B. HESCs were transfected with siRNA targeting ESR1 or scrambled siRNA (control). 48h 
after transfection, HESCs were treated with differentiation cocktail to initiate in vitro 
differentiation. Cells were harvested at 24h following differentiation cocktail treatment. Total 
RNA was isolated and cDNAs were prepared. cDNAs were subjected to real-time PCR using 
gene specific primers for 36B4, ESR1, CCND3, CCNA2, CDC20, GAS1, CDKN1C, E2F1, 
E2F2 and E2F3. PCR data are normalized to 36B4 mRNA levels. Relative fold changes were 
normalized with respect to control non-targeting siRNA treatment. Error bars represent ± 
standard deviation of at least three independent experiments. 
C. HESC were synchronized at G1/S stage by double thymidine block and were transfected with 
siRNA targeting ESR1 or non-targeting control siRNA. 24h after transfection, HESCs were 
treated with differentiation cocktail to initiate in vitro differentiation. At 18h following 
differentiation cocktail treatment, BrdU was added to the medium (100µM). At 6h following 
BrdU addition (24h of differentiation), cells were fixed and subjected to immunofluroscence 
to detect BrdU positive cells, which are indicated in red. DAPI stained nuclei are shown in 
blue. Images are the representatives of three independent experiments. The graph shows the 
mean values of percentages of BrdU positive cells calculated from five different fields, error 
bars represent ± standard deviation. 
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Figure 2.3: FOXO1, WNT4 and PGR are downstream of ESR1 during HESC 
differentiation. 
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Figure 2.3 cont.: 
A. HESCs were transfected with siRNA targeting ESR1 or scrambled siRNA (control). 48h 
after transfection, HESCs were treated with differentiation cocktail to initiate in vitro 
differentiation. Cells were harvested at 24h and 72h following differentiation cocktail 
treatment. Total RNA was isolated and cDNAs were prepared. cDNAs were subjected to 
real-time PCR using gene specific primers for 36B4, PGR, FOXO1 and WNT4. PCR data are 
normalized to 36B4 mRNA levels. Relative fold changes were normalized with respect to 
control non-targeting siRNA treatment. Error bars represent ± standard deviation. 
B. HESCs were transfected with siRNA targeting ESR1, or PGR or scrambled siRNA (control). 
48h after transfection, HESCs were treated with differentiation cocktail to initiate in vitro 
differentiation. Cells were harvested at 24h following differentiation cocktail treatment. Total 
RNA was isolated and cDNAs were prepared. cDNAs were subjected to real-time PCR using 
gene specific primers for 36B4 and FOXO1. PCR data are normalized to 36B4 mRNA levels. 
Relative fold changes were normalized with respect to control non-targeting siRNA 
treatment.  This is a representative of four independent experiments. 
C. HESCs were transfected with siRNA targeting ESR1, or PGR or scrambled siRNA (control). 
48h after transfection, HESCs were treated with differentiation cocktail to initiate in vitro 
differentiation. Cells were lysed at 24h following treatment, analyzed by SDS-PAGE and 
subjected to western blotting using antibodies directed against ESR1, PGR, FOXO1 and 
Calnexin. Calnexin immunoblotting serves as a loading control. 
D. HESCs were hormone starved in 2% charcoal stripped serum containing medium for 48h. 
Then, cells were either untreated or treated with E+P or E+P+cAMP. Cells were harvested at 
24h following each treatment. Total RNA was isolated and cDNAs were prepared. cDNAs 
were subjected to  real-time PCR using gene specific primers for 36B4, FOXO1 and WNT4 . 
PCR data are normalized to 36B4 mRNA levels. Relative fold changes were normalized with 
respect to untreated sample indicated as none in the figure. 
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Figure 2.4: PKA signaling is required for cAMP induced differentiation of HESC 
 
HESCs were transfected with siRNA targeting Protein Kinase A catalytic subunit alpha or 
scrambled siRNA (control). 48h after transfection, HESCs were treated with differentiation 
cocktail to initiate in vitro differentiation. Cells were harvested at 48h following differentiation 
cocktail treatment. Total RNA was isolated and cDNAs were prepared. cDNAs were subjected to  
real-time PCR using gene specific primers for PRKACA, PRL , IGFBP1 and WNT4. PCR data 
are normalized to 36B4 mRNA levels. Relative fold changes were normalized with respect to 
control non-targeting siRNA treatment.  Error bars represent ± SD of three separate 
measurements. 
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Figure 2.5: Identification of proteins phosphorylated by PKA during HESC differentiation 
Band Protein identification Peptide sequence 
1 Coil-coil domain protein R.DEQDFR.N 
2 Non-muscle myosin 9 K.ALSLAR.A,  R.VVFQEFR.Q, 
R.VEEEEERCQHLQAEK.K , 
K.ANLQIDQINTDLNLER.S 
3 Brain 4 Transcription 
Factor/MED1 
K.TDTSCHDL.- 
/K.DNPAQDFSTLYGSSPLER.Q 
4 IgG light chain R.VTISGSGSK.S 
5 MED1 K.AQGETEESEK.L 
6 Phospholipase C K.EAAEPR.T 
7 vimentin R.SSVPGVR.L, R.SYVTTSTR.T, 
R.QQYESVAAK.N,  R.ISLPLPNFSS
LNLR.E 
 8 Peroxisome biogenesis factor K.GMMKELQTK.Q 
9 MED1 K.VTSLPAMTDR.L, 
K.AQGETEESEK.L 
10 Skeletal tropomyosin R.AELSEGQVR.Q, 
R.IQLVEEELDR.A 
A. 
198 
128 
93 
38 
E+P+cAMP 
H89 
+ + 
+ - 
200kD 
116kD 
97kD 
66kD 
45kD 
31kD 
B. 
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250kD 
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75kD 
50kD 
37kD 
25kD 
1 
2 
3 
4 
6 
5 
7 
8 
9 
10 
none E+P+cAMP C. 
D. E. 
P-MED1 
MED1 
cAMP+E+P none 
IP: MED1 
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Figure 2.5 cont.: 
A. HESC were untreated or treated with E+P or E+P+cAMP. Cells were lysed at 3h following 
treatment, analyzed by SDS-PAGE and subjected to Western Blotting using phospho-PKA 
substrate antibody. Data is representative of six independent experiments. 
B. HESC were treated with either vehicle or with the PKA inhibitor H89. Following inhibitor 
treatment, cells were treated with differentiation cocktail, composed of E+P+cAMP. Cells 
were lysed at 24h following treatment, analyzed by SDS-PAGE and subjected to Western 
Blotting using phospho-PKA substrate antibody. Lane 1: vehicle, with differentiation 
cocktail, lane 2: H89, with differentiation cocktail.  
C. HESC were either untreated or treated with differentiation cocktail, composed of 
E+P+cAMP. At 24h following treatment, cells were harvested and lysed. Whole cell lysates 
from each sample were immunoprecipitated with phospho-PKA substrates antibody to pull 
down phosphorylated targets of PKA. Bound proteins were eluted and analyzed by SDS 
PAGE followed by silver staining as explained in materials and methods. Arrows indicate the 
bands which are submitted for protein identification by mass spectrometry. 
D. HESC were either untreated or treated with differentiation cocktail, composed of 
E+P+cAMP for 24h. Whole cell lysates from HESC were immunoprecipitated with MED1 
antibody. The immunoprotein complexes were then probed by western blot using phospho-
PKA substrate antibody or MED1 antibody as indicated in the figure. 
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Figure 2.6: Interaction between MED1 and ESR1 in HESC 
A. HESC were infected with adenovirus  expressing flag tagged ESR1 for 24h, following 
transfection, cells were treated with the differentiation cocktail composed of E+P+CAMP for 
3h. Whole cell lysates from HESC were immunoprecipitated with MED1 antibody or normal 
rabbit IgG as a negative control. The immunoprotein complexes were then probed by western 
blot using ESR1 antibody. 
B. HESC were infected with adenovirus expressing flag tagged ESR1 for 24h, following 
transfection, cells were treated with the differentiation cocktail for 3h. Whole cell lysates 
from HESC were immunoprecipitated with anti-flag M2 antibody coupled to beads to pull 
down exogenously expressed flag-tagged ESR1. Bound proteins were eluted with FLAG 
peptide and analyzed by SDS PAGE and western blot using MED1 antibody, phospho-PKA 
substrate antibody and ESR1 antibody. Figure is the representative of two independent 
experiments. 
C. HESC were infected with adenovirus expressing flag tagged ESR1 for 24h, following 
transfection, cells were treated with E+P or E+P+cAMP for 3h. Whole cell lysates from 
HESC were immunoprecipitated with anti-MED1 antibody coupled to beads. Bound proteins 
were analyzed by SDS PAGE and western blot using ESR1 antibody. Figure is the 
representative of three independent experiments. 
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Figure 2.7: MED1 is required for cAMP induced differentiation of HESC. 
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Fig. 2.7 cont.: 
A. HESCs were transfected with siRNA targeting MED1 or non-targeting scrambled siRNA for 
48h. After siRNA treatment, cells were treated with differentiation cocktail composed of 
0.5mM 8-Br-cAMP + 10 μM P + 10nM E for 72h. Real time-PCR was performed to analyze 
gene expression using specific primers for MED1, ESR1, PRL and IGFBP1; values are 
normalized to control siRNA treatment. The graph represents mean ± SD of three 
independent experiments. 
B. HESCs were transfected with siRNA targeting MED1 or control siRNA. 48h after 
transfection, HESCs were treated with differentiation cocktail to initiate in vitro 
differentiation.  At 72h of differentiation, cells were visualized under bright field microscope 
to monitor decidual morphology. Data is representative of four experiments. 
C. HESCs were transfected with siRNA targeting MED1 or non-targeting scrambled siRNA for 
48h. After siRNA treatment, cells were treated with differentiation cocktail. Cells were 
harvested at 24h following differentiation cocktail addition. For gene expression analysis, Q-
PCR was performed using specific primers for WNT4; values are normalized to control 
siRNA treatment. The graph represents mean ± SD of six independent experiments. 
D. HESC were transduced with recombinant adenovirus harboring flag-tagged ESR1 for 24 h. 
Samples were treated with E+P+cAMP for 1h. ChIP was performed as described in material 
and methods section. Chromatin enrichment was quantified by real-time PCR using primers 
flanking potential ESR1 binding sites upstream of and in the WNT4 gene. The experiment 
was repeated twice and representative data are shown. 
E. ChIP was performed under similar conditions with section D to immunoprecipitate MED1 
bound chromatin as explained in materials and methods. Primers flanking potential ESR1 
bound regulatory regions and promoter of WNT4 gene, indicated as WNT4 -700bp, were 
used to quantify chromatin enrichment. The graph represents mean ± SD of three 
independent experiments. 
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Figure 2.8: Proposed model for role of ESR1 and cAMP during HESC differentiation 
ESR1 has two main roles in HESC differentiation: (i) it suppresses proliferation of HESC by 
suppressing the expression of cell cycle regulators; (ii) ESR1 induces the differentiation of 
HESC by inducing the expression of important regulators of HESC differentiation, namely 
FOXO1, WNT4 and PGR. PKA signaling is the principal signaling pathway downstream of 
cAMP. MED1 is phosphorylated by PKA and interacts with ESR1 and is critical for HESC 
differentiation and expression of ESR1 target genes. 
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CHAPTER III 
ROLE OF PROGESTERONE RECEPTOR ISOFORMS DURING HUMAN 
ENDOMETRIAL STROMAL CELL DIFFERENTIATION 
 
ABSTRACT 
Progesterone, acting through progesterone receptors (PRs), is known to be one of the 
most critical regulators of endometrial differentiation. Yet, a long-standing unresolved issue in 
uterine biology is the precise roles of the progesterone receptor isoforms, PRA and PRB, during 
endometrial differentiation in the human. Our approach, expressing PRA and PRB individually 
after silencing endogenous PRs in human endometrial stromal cells (HESC), enabled the analysis 
of the roles of the isoforms separately as well as jointly. We found that PRB has a larger 
cistrome, which includes the majority of PRA binding sites. De novo motif analysis showed that, 
while both isoforms bind to the same DNA sequence motif, they had both common and distinct 
nearby motifs where other transcription factors bind. Our comprehensive gene expression 
analysis suggested that PRA and PRB regulated overlapping and distinct sets of genes, many of 
which are critical for decidualization and establishment of pregnancy. When PRA and PRB were 
co-expressed, PRB was the prevalent isoform, although both isoforms influenced each other’s 
transcriptional activity. Our ChIP-seq and genome-wide gene expression analyses suggested that 
PRB is a more effective transcription factor than PRA during HESC differentiation.  With this 
study, we confirmed some of the known roles of progesterone, such as regulation of cell cycle, 
angiogenesis, apoptosis and expression of some essential signaling molecules, for stromal 
differentiation. We were also able to distinguish signaling networks downstream of each isoform 
and find novel molecules, such as IRS2, as potential direct targets of progesterone signaling to 
support a successful pregnancy.  
 
INTRODUCTION 
Decidualization, the differentiation of endometrium into a unique tissue, which supports 
the implanted embryo, is one of the most critical processes in the establishment of a successful 
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pregnancy. Decidualization is a complex event, every step of which is regulated by many 
transcription factors and signaling molecules in a timely manner. Progesterone (P), secreted from 
ovaries following ovulation, is one of the earliest and most important regulators of endometrial 
differentiation. It has been well established that P, acting through its nuclear receptors, PRs, is 
required for the precise and timely regulation of this process [1-6]. Several in vitro and in vivo 
studies, including characterization of the PR knockout mouse, have established a key role of 
progesterone receptor during decidualization in humans and mice [5] [7, 8].  
Progesterone receptor has two isoforms, PRA and PRB, which are transcribed from the 
same gene [9]. Despite having the same DNA binding and ligand binding domains, PRA and 
PRB can have very different activities in the cell. The dissimilarities in their transcriptional 
activities originate from the differences in their N terminal regions, as PRB has an additional 
transactivation domain that interacts with cofactors [10]. A number of cell-based reporter assays 
suggested that PRA could act as a repressor of PRB transcriptional activity at some promoters 
[11, 12]. Studies in prostate stroma and breast cancer cell lines showed that PRA and PRB 
regulated different gene networks and their relative expression levels, which change in some 
breast cancer types, might affect downstream gene expression [13-15].  
Both isoforms are expressed in the endometrial stroma and their relative levels change 
throughout the menstrual cycle [16]. In the early proliferative stage, PRB level is very low, while 
PRA levels are high. During the peri-ovulatory period, expression of both isoforms increase.  
The induction of PRB is more robust, its level becoming comparable to that of PRA. By late 
secretory phase, both PRA and PRB expression start to decline and their levels return to those 
seen in early proliferative phase [16, 17].  
Some endometrial disorders show aberrant expression and relative ratios of PRA and 
PRB, underlining the importance of distinguishing between the roles of these isoforms so that we 
can have a better understanding of their biology, their role in gynecological pathologies, and to 
develop treatment strategies for diseases. Although, the molecular pathways via which the 
progesterone receptors exert their effects during decidualization have been addressed in some 
studies [6, 7, 18], we are still far away from understanding the downstream signaling 
mechanisms of each isoform during decidualization in the human. 
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Our approach, expressing PRA and PRB individually after silencing endogenous 
isoforms, allowed the identification of their genome-wide binding sites and downstream gene 
networks separately. Using this approach, we showed that they both bound to the same DNA 
sequence motif, but PRB had a larger number of binding sites. We also found that they had both 
common and unique neighboring motifs nearby where other transcription factors bind, 
suggesting the presence of different interaction partners. PRA and PRB showed common and 
distinct downstream gene networks when expressed individually. Signaling pathways identified 
downstream of the isoforms, including regulation of angiogenesis, apoptosis and cell cycle, are 
known to be critical components of the endometrial differentiation process. We also observed 
that PRA and PRB modulate each other’s activity when they are co-expressed. Therefore we 
believe that our study, which aims to explore the roles of both isoforms during endometrial 
differentiation, is an important step for furthering our understanding of the roles of progesterone 
receptor isoforms in human uterine biology. 
 
MATERIALS AND METHODS 
Primary HESC culture  
The primary human endometrial stromal cells (HESC) were provided by Dr. Robert Taylor of 
Emory University Medical School and Wake Forest School of Medicine. HESC were isolated 
from biopsies collected from proliferative stage endometrium of normal cycling women with no 
sign of uterine abnormality and with the volunteer’s informed consent.  These cells were cultured 
in DMEM/F-12 medium (Invitrogen) supplemented with 5% (v/v) fetal bovine serum (Hyclone), 
50µg/ml penicillin and 50µg/ml streptomycin (Invitrogen). HESC of passage number nine or 
earlier were used in this study. For in vitro differentiation, the cells were treated with 
differentiation cocktail composed of 0.5mM 8-bromo-adenosine-3’,5’-cyclic monophosphate (8-
Br-cAMP) (Sigma), 1µM progesterone (Sigma) and 10nM 17-β-estradiol (Sigma) in DMEM/F-
12 medium (Invitrogen) supplemented with 2% (v/v) charcoal dextran stripped fetal bovine 
serum. The medium/ differentiation cocktail was refreshed every 48h. 
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siRNA transfection and adenovirus transduction 
HESC were transfected with siRNA targeting the 3’utr of progesterone receptor mRNA 
(Dharmacon) or non-targeting control siRNA (Dharmacon) following manufacturer’s protocol 
(SilentFect, Bio-Rad Laboratories). Briefly, a final concentration of 50nM siRNA was mixed 
together with 5µl of SilentFect to transfect the cells. At 24h following siRNA treatment, cells 
were transduced with the adenovirus expressing flag tagged PRA or PRB for 24h. The 
adenovirus is kindly provided by laboratory of Prof. Dean Edwards of Baylor College of 
Medicine. At 48h of siRNA transfection and 24h of concurrent adenovirus transduction, medium 
was removed; cells were washed with PBS and treated with differentiation cocktail for time 
periods as indicated in the figure legends.  
Western Blot Analysis 
Primary HESCs were subjected to different treatments as indicated in the figure legends for 
indicated periods of time. Whole cell extracts were prepared and equal amounts of proteins were 
analyzed by SDS-PAGE, transferred to PVDF membrane and the specific proteins were detected 
by Western blotting using the antibody against Calnexin (Santa Cruz), and PR. PR antibody was 
kindly provided by Prof. Dean Edwards of Baylor College of Medicine. 
Chromatin immunoprecipitation 
ChIP assays were performed using the EZ-ChIP kit (Millipore) according to the manufacturer's 
instructions with minor modifications. HESC were seeded on 150mm dishes. After cells were 
attached, medium was switched to 2% (v/v) charcoal dextran stripped fetal bovine serum 
containing medium. When reached 70-80% confluency, cells were transfected with siRNA 24h 
and then transduced with adenovirus carrying flag-tagged PRA or PRB or empty vector 
(negative control) for 24h.  Next day, cells were treated with E+P+8-Br-cAMP for 2h. Cells were 
fixed with 1% formaldehyde for 10 min and excess formaldehyde was quenched with 0.25 M 
glycine for 5 min. Cells were then washed twice with cold PBS, scraped and collected in PBS 
containing protease inhibitors in a conical tube, and centrifuged. Cell pellets were resuspended in 
lysis buffer containing protease inhibitors for 15 min to lyse the cells. Next, chromatin was 
sonicated in four 15-s pulses on power 4; with cooling between pulses (Fisher Scientiﬁc model 
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100 Sonic Dismembrator). One percent of the cell lysate was used for input control. The 
remainder of the lysate was incubated with anti-flag M2 affinity gel (Sigma, A2220) overnight at 
4
0
C to isolate the immune complexes (flag-PRA and flag-PRB). For CEBPB ChIP, an antibody 
against CEBPB (Santa Cruz; sc-150) and for negative control mock IgG (Santa Cruz sc-2027) 
were used. Complexes were washed with low salt, high salt, LiCl buffers and twice with TE 
buffers, eluted from the beads and heated at 65°C for 6 hours to reverse the cross-linking. 
Following digestion with RNAase A and proteinase K, DNA fragments were purified using 
QIAquick PCR purification kit (Qiagen). For ChIP real-time quantitative PCR, primers were 
designed to amplify potential binding sites. The resulting signals were normalized to input DNA 
and relative fold enrichment was calculated as the enrichment in experimental samples over that 
of negative control ChIP.  
Microarray sample preparation and data analysis 
HESC were transfected with siRNA targeting PGR mRNA (Dharmacon) or non-targeting control 
siRNA (Dharmacon) as explained above. At 24h following siRNA treatment, cells were 
transduced with the adenovirus expressing flag tagged PRA, PRB or PRA-PRB both for 24h.  
Next day, cells were washed with PBS and treated with differentiation cocktail for 6h. We 
performed two independent microarray experiment sets using two different clinical samples. 
Total RNA was isolated by Trizol reagent (Invitrogen, CA) and further purified using RNeasy 
columns (Qiagen) following manufacturer’s instructions. RNA samples were processed at the 
Biotechnology Center of the University of Illinois at Urbana-Champaign. RNA integrity was 
verified using Agilent 2100 Bioanalyzer. Each RNA sample was processed to generate labeled 
cRNA following established protocols for hybridization to the GeneChip Human Genome 
U133A 2 arrays. The resulting data files were first normalized and analyzed by Affymetrix 
GeneChip Expression Console software using RMA algorithm. Genes with a minimum of 1.2-
fold-change in the same direction in both microarrays were considered as differentially regulated 
genes.  
RNA Isolation and Real-time PCR Analysis 
Total RNA was extracted from cultured HESC using Trizol (Invitrogen) according to 
manufacturer’s instructions. Total RNA was subjected to cDNA conversion using Stratagene 
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cDNA conversion kit, following manufacturer’s instructions. cDNA were subjected to 
quantitative PCR analysis using gene specific primers. Sequences of real time PCR primers are 
available upon request. 36B4 was used as the internal control. For a given sample, threshold 
cycle (Ct) and (standard deviation) SD was calculated from individual Ct values from three 
replicates of a sample. Normalized mean Ct (ΔCt) was calculated by subtracting mean Ct of 
36B4 from mean Ct of a target gene for control sample. ΔΔCt was then calculated for each gene 
as a difference in ΔCt values between control and sample. Fold change in gene expression was 
then computed as 2-ΔΔCt. Results are expressed as mean ± SD of three different measurements. 
Statistical significance between the control and experimental sample was determined using 
student t-test. A p-value of ≤0.05 was considered to be significant. Statistical significance within 
a group of experimental samples was determined using one-way ANOVA followed by Tukey 
mean comparison test.  A p-value of <0.05 was considered significant. 
 
RESULTS 
Roles of PRA and PRB can be analyzed individually during HESC differentiation 
Undifferentiated HESCs express both isoforms of progesterone receptor at low levels. Upon 
addition of differentiation cocktail composed of estrogen (E), progesterone (P) and cAMP analog 
(cAMP), levels of both isoforms increase significantly, though more pronounced in PRB levels 
(Fig. 3.1A). After 24 h of hormone cocktail treatment, both isoforms are expressed at comparable 
levels in differentiating HESC. To analyze the roles of each isoform separately, we used a 
strategy to generate HESC expressing only one of the isoforms.. In our approach we transiently 
silenced the expression of endogenous receptor and then reconstituted the expression of each 
isoform individually by transient transduction with an adenovirus harboring the cDNA of the 
isoform. Endogenous PR was depleted in HESC by transfecting the cells with siRNA targeted to 
the 3’-untranslated region (UTR) of the PR mRNA. Next, cells were transduced with adenovirus 
harboring flag-tagged PRA or PRB cDNA lacking the 3’ UTR or a control virus carrying the 
empty vector. This strategy allowed the reconstitution of PRA or PRB expression in the HESC 
and created conditions under which the biological activity of either PRA or PRB can be tested 
independently (Fig. 3.1B). To ascertain that the protein levels of exogenously expressed isoforms 
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are comparable to their endogenous levels, we employed western blot analysis using an antibody 
that recognizes both PRA and PRB (Fig. 3.1C). We next tested the biological activity of the flag-
tagged PRA or PRB by monitoring their ability to rescue differentiation following the knock-
down of endogenous PR. For this purpose, we monitored the expression of transcripts of PRL 
and IGFBP1, two well-known markers of stromal differentiation. In response to siRNA-mediated 
knockdown of endogenous PRA and PRB, the expressions of PRL and IGFBP1 were strongly 
down regulated (Fig. 3.1D). Reconstitution of PRB expression fully restored the IGFBP1 and 
PRL mRNA expression, while the rescue of the expression of these mRNAs by PRA was slightly 
less effective. These results support our view that adenovirus-induced flag-PRA and flag-PRB 
are biologically active and able to restore stromal differentiation, although they may differ in 
their inherent capacities to control this process.  
Genome-wide PRA and PRB binding locations in – HESC during decidualization 
In order to map the genomic binding sites of the P-R isoforms in differentiating HESC, 
we employed chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-
seq).  HESC depleted of endogenous P-R isoforms and expressing adenovirus-induced flag-PRA 
or flag-PRB were treated with differentiation cocktail for 2 h. ChIP assays were performed using 
an antibody specific for the flag epitope. Purified chromatin samples were sequenced using the 
Illumina platform. For mapping the Illumina sequencing reads to the human genome, we used 
the Bowtie software package [19]. Mapped reads were then analyzed with the MACs program 
[20] to identify peaks enriched in PRA ChIP or PRB ChIP samples compared to both genomic 
input and mock-ChIP controls. Mock-ChIP control was used as an internal control for validation 
of the specificity of the antibodies used for pulling down flag-tagged proteins. To identify 
genomic binding sites for each isoform, we used genomic input DNA comparison and for further 
analysis we considered sequences with a false discovery rate (FDR) ≤5% and fold enrichment 
(FE) ≥5. We identified 8248 genome-wide binding sites for PRA and 15109 for PRB. The 
majority of PRA binding sites were common to PRB, while PRB also occupied many unique 
binding sites (Fig. 3.2A). A subset of target sequences common to both PRA and PRB ChIP-seq 
data were selected for further validation by ChIP-RT-qPCR using different clinical samples (Fig. 
3.2B). To further characterize the binding sites, we mapped the enriched regions identified by 
PRA and PRB ChIP-seq with custom defined genomic regions using CEAS (Enrichment on 
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chromosome and annotation) tool of Cistrome. We defined regions at 2500bp, 5000bp and 
10000bp upstream of transcriptional start sites (TSS) as promoter – lower, -middle and –upper 
intervals. The majority of both PRA and PRB enriched regions were either distal intergenic 
regions or introns (Fig. 3.2C). 
PRB regulates PRA 
We identified two PR binding sites in the P-R gene itself.  Interestingly, these sites were 
bound by PRB but not PRA. The binding site in the first exon of the P-R gene mostly overlapped 
with the sequence previously reported to be a PRA promoter (Fig. 3.2D) [9], suggesting that 
PRB might be binding to the PRA promoter to regulate its expression. We validated PRB 
binding to this region by ChIP, while PRA showed no enrichment (Fig. 3.2E). Since PRA shares 
a common coding sequence with PRB, it was not possible to monitor PRA mRNA levels 
independent of PRB mRNA to assess the possible transcriptional regulation of PRA by PRB. 
Therefore, we analyzed how the expression of exogenous PRA affects the PRB protein levels 
and vice versa. With increasing levels of exogenously expressed PRA, no noticeable increase in 
PRB protein levels was detected. In contrast, we observed a considerable increase in PRA 
protein levels in response to increasing levels of exogenously expressed PRB (Fig. 3.2F); 
consistent with the concept that PRB regulates PRA expression by directly binding to its 
promoter.  
Analysis of transcription factor binding motifs associated with PRA and PRB binding sites 
In order to identify enriched transcription factor binding motifs in the PR binding sites 
identified by ChIP-seq, we applied the de novo motif detection tools MEME [21] and SeqPos 
[22] to analyze sequences within ±100bp of the summits of PRA and PRB binding sites.  Motif 
analysis of both PRA and PRB binding sites identified G.ACA…TGT.C as the major motif, 
which did not differ between the two isoforms (Fig. 3.3A). This motif, which is identical to the 
progesterone response element described previously [18] was located centrally within the 200bp 
sequence spanning the summit, (Fig. 3.3B). Figure 3.3C shows the number and overlap of 
additional motifs observed in each isoform’s target sequences. A description of the motifs 
observed in the 200nt sequence around the summits of PRA and PRB binding sites are listed in 
Tables 3.1 and 3.2. We found several motifs common for both isoforms. One of these is an AR 
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binding motif, which is essentially the same as the PRE. It is known that PR and AR recognize 
the same binding motif. The other motifs represented the binding sites of various transcription 
factors, such as JUN, SOX10, CEBPA, CEBPB, FOXP1, HIF1A, REST, PAX1 and MTF1. The 
JUN motif was one of the most abundant motifs in both PRA and PRB target sequences. It was 
also identified as a prominent motif in the mouse PR cistrome [18]. Interestingly, JUN and FOS 
motifs were found more frequently in PRA bound sites than that of PRB. Motifs unique to PRA 
included HOXA2. Motifs unique to PRB included BCL6, STATs, TRP63 and RARA. In order to 
assess whether these nearby motifs were actual binding sites for corresponding transcription 
factors, we selected PRA and PRB binding sites that contained the CEBPB motif and analyzed 
the chromatin enrichment of this factor by ChIP. As shown in Fig. 3.3D, sequences which had 
CEBPB motif were significantly enriched, while there was no enrichment in a control sequence 
lacking CEBPB motif. 
Genes regulated by PR isoforms in differentiating human endometrial stromal cells 
The first step in understanding the molecular signaling downstream of each isoforms is to 
identify potential direct targets of PRA and PRB. We performed mRNA profiling to correlate 
genome binding to gene expression regulation. For the microarray analysis, HESC were 
transfected with control siRNA or with siRNA targeting 3’UTR of PR mRNA. SiRNA mediated 
knockdown was followed by transduction with adenovirus harboring flag-tagged PRA or PRB 
cDNA or a control virus carrying the empty vector. Importantly, we also co-expressed PRA and 
PRB to see whether the presence of one isoform influences the transcriptional activity of the 
other. Our analysis yielded 451, 1724, and 1636 differentially regulated genes in HESC 
expressing PRA alone, PRB alone and PRA+PRB, respectively, compared with HESC 
transduced with control virus. We next assessed the percentage of PRA or PRB upregulated and 
downregulated genes that had at least one PRA or PRB-binding site within ±100 kb of their 
TSSs. About 40% of genes regulated by PRA had a PRA binding site while 60% of genes 
regulated by PRB contained a PRB binding site (Fig. 3.4D and Fig. 3.4E). We verified that 
several genes previously reported to be progesterone-regulated indeed possess PRA or PRB 
binding sites and their expression was regulated by progesterone. , For example, the BMP2 gene 
[23], displayed multiple binding sites for both PRA and PRB and its expression was increased by 
PRB at 6 h. We also examined whether the neighboring motifs determine the direction of 
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regulation of target genes. We noted that, in PRB binding sites of down regulated genes, STAT 
and REST motifs were enriched, while CEBP, HIF1A and ELK motifs were enriched in the PRB 
binding sites of up regulated genes. To have a better understanding of the key biological 
functions associated with the gene pathways downstream of PRA and PRB, we classified them 
into various biological categories, using DAVID [24, 25] and PANTHER. 
We found that about 25% of genes regulated by PRA overlapped with PRB-regulated 
genes (Fig. 3.4A).  These common pathways included genes that regulate response to external 
stimulus, blood vessel development, regulation of blood coagulation, and response to hypoxia. 
PRA-regulated genes encoded several protein kinases, and transcription factors involved 
in the regulation of apoptosis (including TNFSF12, BCL6, CFLAR, MCL1 and BIRC5), and 
factors involved in blood vessel development (including CYR61 and VEGFA) (Table 3.3).  
Our analysis highlighted the predominant roles of PRB in the regulation of the cell cycle, 
angiogenesis, lysosomal activity and secretion of chemokines and cytokines (Table 3.4). Genes 
upregulated by PRB included several signaling molecules involved in angiogenesis, apoptosis 
and cell adhesion, and numerous solute carrier family members. Interestingly, many genes 
regulating the mitotic phase of the cell cycle, including CCNB1, CCNB2, CDC20, CDC25A, 
CDK1 and BUB1, were suppressed by PRB (Fig 3.5A), suggesting that the PRB isoform may be 
playing a critical role in suppression of cell proliferation during the differentiation process of 
HESC. It is generally observed that the cell cycle exit is a pre-requisite for differentiation. Our 
laboratory and others have observed that proliferation of HESC ceased at the initiation of the 
differentiation program [26]. The exit from the cell cycle is a key step in HESC differentiation 
and it is potentially regulated by PRB.  
Angiogenesis appears to be another biological process regulated by PRB. We found 
several genes, including VEGFA, ANGPT2, ANGPTL4, EPAS1, EREG, TGFB2, EGFR, FGF2 
and TNFAIP,2 that are up-regulated by PRB.   Formation of new maternal blood vessels is 
critical for implantation and survival of the embryo, and progesterone is known to stimulate 
angiogenesis during decidualization. Many of these genes, such as VEGFA, TGFB2, ANGPT2, 
ANGPTL4 and EGFR, harbor PRB binding sites, indicating that they are direct targets of PRB. 
We validated the induction of several of these genes by PRB using real-time PCR (Fig. 3.5B).  
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When both isoforms were co-expressed, differentially regulated genes were more 
commonly associated with PRB (Table 3.5, Fig. 3.4B, 3.4C). However, PRA clearly modulated 
PRB activity as the magnitudes of expression of several genes were altered when both isoforms 
were co-expressed. These genes included numerous glycoproteins involved in cell signaling and 
immunoregulation, ion channels, peroxisome-related genes, and certain peptidases involved in 
lysosomal processes.  
IRS2, a PR-regulated metabolic molecule, controls decidualization  
We identified several components of the insulin signaling pathway, including insulin 
receptor substrate 2 (IRS2), SHC-transforming proteins 1 and 3 (SHC1 and SHC3), GRB10 and 
SOS1 downstream of PRB. Among them, IRS2 contained binding sites for both PRA and PRB at 
88kb upstream of its TSS, in addition to several other binding sites farther upstream or 
downstream of its open reading frame. We monitored IRS2 expression in primary cultures of 
differentiating HESC. Addition of differentiation cocktail led to an increase in IRS2 mRNA 
levels within 24 h (data not shown). To establish IRS2 as a direct target of PR, we validated the 
binding of PRA and PRB to the -88kb upstream region and an additional region further 
upstream. Both PRA and PRB were recruited to these regions (Fig 3.6A). Next, we confirmed 
transcriptional regulation of IRS2 by PRA and PRB at 24 h of HESC differentiation. When 
endogenous PR was silenced by siRNA targeting 3’utr region of its mRNA, IRS2 expression was 
also downregulated. Reconstitution of PRA and PRB expression restored the IRS2 mRNA 
expression (Fig. 3.6B). To test the possibility of a potential role of IRS2 in HESC differentiation, 
we examined the effect of this down regulation on the differentiation process. Analysis of 
mRNAs corresponding to PRL, IGFBP1 and WNT4, well-known biochemical markers of 
decidualization, by real-time RT-PCR, revealed a significant decrease in the expression of 
IGFBP1 and WNT4 (Fig. 3.6C). Similar to the gene expression changes, indicating a lack of 
stromal differentiation in the absence of IRS2, there was impairment in the morphological 
changes associated with the decidualization process (data not shown). Therefore, we concluded 
that IRS2 is a potential direct target of progesterone receptor and is critical for the differentiation 
of HESC.  
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DISCUSSION 
In the present study, we aimed to identify the downstream gene networks and potential direct 
targets of progesterone receptor isoforms, PRA and PRB, during human stromal differentiation. 
Both isoforms were expressed at comparable levels in differentiating HESC (Fig. 3.1A) and 
capable of inducing stromal decidualization as measured by the expression of classical 
decidualization biomarkers, IGFBP1 and PRL (Fig. 3.1D), suggesting that both isoforms played 
critical regulatory roles during stromal differentiation.  
Since they are expressed from the same gene, PRA and PRB have the same DNA binding 
and ligand binding domains, but they have very different biological activities due to the 
differences in their N terminal regions. PRB has a B-upstream segment (BUS) which can interact 
with adjacent PRB dimers, different transcription factors and co-activators [10, 11, 27].  By our 
unbiased genome-wide approach, we identified cistromes of PRA and PRB at an early time point 
of in vitro differentiation. We found that PRB had a greater number of binding regions in the 
genome, including the majority of the PRA binding sites (Fig. 3.2A).  This suggested that PRB 
might have a larger transcriptome compared to PRA. There are several possible mechanisms by 
which this may happen, including cooperative interactions between PRB homodimers occupying 
multiple adjacent PR binding sites and interactions with other factors that bind to nearby motifs. 
When we analyzed the motifs within a ±100bp window from the summits of target sequences of 
PRA and PRB, we identified motifs that were unique to PRA (BACHs and HOXA2) and PRB 
(BCL6, STATs, TRP63, and RARA). In addition, PRA and PRB had common nearby including 
JUN, CEBPs, SOXs, REST and ESR1, some of which had been observed previously in the 
mouse PR cistrome [18].  
These motifs, which bind to other transcription factors, may serve as indirect binding sites for 
PRA or PRB through tethering mechanisms. Consistent with this view, it has been proposed that 
certain pioneering transcription factors modulate chromatin availability for PRs [28]. 
Alternatively, PRA or PRB, bound directly to target DNA, may interact with other transcription 
factors, such as CEBPB, STAT3, and HIF1A, and these interactions might be critical for a 
cooperative regulation of target gene expression. This adds another level of complexity to the 
pattern of temporal regulation of PR target genes, since activation and nuclear localization of 
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some of these factors occur hours to days after differentiation stimulus. For example, we 
observed nuclear localization of STAT3 in HESC 24 hours after stimulation with the 
differentiation cocktail [26]. Notably, these findings suggest that PR can potentially undergo 
direct protein-protein interactions with previously identified critical regulators of stromal 
differentiation, including CEBPB, HOXA10, STATs, HIF1A and FOXO [26, 29-31]. Previous 
studies speculated that PR undergoes functional interactions with FOXO1, STAT3 and CEBPB 
to regulate the expression of target genes in differentiating stromal cells [30-32]. In support of 
this theory, we showed a significant enrichment of CEBPB on several progesterone receptor 
binding sites identified in our study, suggesting that coordinate gene regulation involving PR and 
these transcription factors are critical for target gene expression and decidualization. 
Similar to other steroid receptors [33, 34], binding sites for the PR isoforms were localized 
further away from the TSS of the closest genes, mostly in introns or intergenic regions (Fig. 
3.2B). Further characterization revealed that about 80% of all binding regions overlapped with 
enhancer- promoter- associated histone marks (layered H3K4Me1 and hypersensitive sites) [35], 
resembling distant enhancers (data not shown).  For example, we identified multiple PRB 
binding sites, scattered in the region where all 11 members of the family of pregnancy specific 
glycoproteins (PSGs) are clustered in chromosome 19 [36] (Fig. 3.7A). The majority of these 
binding sequences corresponded with layered H3K4Me1 available in UCSC Genome Browser 
[37, 38]. Our microarray results confirmed that the - expression- of several PSGs, including 
PSG1, PSG2, PSG4, PSG5, PSG7 and PSG9, is regulated by PRB. We selected PSG4 as a 
representative gene among this cluster and validated progesterone receptor enrichment by ChIP 
and its up-regulation by PRB, using real-time PCR (Fig. 3.7B and 3.7C). Since there were 
multiple PRB binding sites around PSG4, it gave us an opportunity to test the possible functional 
role of the distal binding sites. For this purpose, we employed chromosome conformation capture 
(3C) assay on two PRB binding sites; one between exon 3 and exon 4 of PSG4 and another 
located about 80kb upstream of PSG4 TSS. Our aim was to examine possible interaction 
between a distant binding site located in an enhancer-like region and proximal binding 
sites/promoter of a PR target gene-.  Remarkably, our results were consistent with an interaction 
between these two binding sites in HESC expressing PRB and this interaction was seen only in 
the presence of the differentiation cocktail (Fig. 3.7D). This experiment- indicated that 
progesterone receptor bound to distal sites may facilitate transcription of its target gene by a 
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looping mechanism.  It is conceivable that, in uterine tissue, both PRA and PRB regulate the 
expression of the majority of their target genes through long-range enhancer interactions rather 
than binding to promoter proximal regions of the target genes. 
Our findings are consistent with the idea that other factors might be involved in regulation of 
gene expression by PR isoforms. Gene expression analysis during HESC differentiation revealed 
that only a small fraction of downstream genes of PRA and PRB was common. We believe that 
interaction of PRA and PRB with specific nearby motifs, such as STATs for PRB and HOXAs 
for PRA, might contribute to the differences we see in the downstream gene networks. STATs 
have been reported to be critical for HESC differentiation, presumably via direct interactions 
with PRB [39]. Interestingly, when we grouped genes downstream of PRB according to their 
direction of regulation, the REST (RE1-Silencing Transcription factor) motif was enriched more 
in repressed genes while CEBPB, HIF1, ELKx and ETVx motifs were found more in 
upregulated genes, suggesting that the presence of specific transcription factors near a PR 
binding site may dictate the direction of regulation of the target gene. 
Our gene expression analysis, using HESC expressing PRA, PRB, or a combination of PRA 
and PRB, provided  a comprehensive view of the pathways regulated by progesterone signaling 
during decidualization These included (i) the distinct pathways regulated by each receptor 
isoform, (ii) common pathways regulated by both, and (iii) unique pathways that were regulated 
when both receptor isoforms were present. More than half of the genes found downstream of 
PRA and PRB at 6 h of differentiation contained at least one PRA or PRB binding site within 
100kb from its TSS, suggesting that they may be direct targets of progesterone signaling. Several 
of these genes, such as BMP2, STAT3, WNT4, HOXA10, and HAND2 are critical for HESC 
differentiation [40]. Many of the potential direct targets of both PRA and PRB were found to be 
involved in regulation of angiogenesis, immune response, cell cycle, apoptosis and cell-matrix 
interactions. We believe that all of these functional categories are critical for decidualization and 
maintenance of pregnancy. We will briefly discuss some of these critical biological processes. 
Cell cycle regulation: Our microarray analysis revealed that, in differentiating HESC, many 
genes involved in M phase of the cell cycle, including CCNB2, CDC25A, CDC25C, CDK1 and 
AURKA, were repressed in HESC expressing either PRB and PRA+PRB. It is generally 
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observed that the cell cycle exit is needed for differentiation [41]. We and others have observed 
that HESC, which proliferate well in the growth medium, ceased proliferation with the addition 
of differentiation cocktail [26]. We suggest that PRB may be contributing to the transition of 
HESC from a proliferating state to a differentiating state by suppressing G2M progression. , The 
biological relevance of this is found in the increase in PRB expression in human endometrial 
stromal cells at the periovulatory period as they begin to differentiate and transit from a 
proliferative to a secretory phase of the cycle. 
Angiogenesis: Angiogenesis is essential for normal endometrial development and for 
placentation. New blood vessels must be formed in the decidua during pregnancy to support the 
developing embryo. Many diseases of pregnancy, such as premature termination and fetal growth 
restriction, have been associated with abnormal angiogenesis[42]. Our e gene expression 
profiling analysis showed that although both PRA and PRB regulate several genes involved in 
angiogenesis, PRB was the predominant regulator of this process. Angiogenesis related genes 
found downstream of PRB included VEGFA, ANGPT2, ANGPTL4 and FGF2. Among them, 
ANGPT2, ANGPTL4 and FGF2 contained PRB binding sites upstream of their TSS, suggesting 
that they are direct targets of PRB. The vascular endothelial growth factor (VEGFA), a key 
angiogenic factor in human endometrium, was previously shown to be regulated by progesterone 
in the uterus [43]. In our study, we found VEGFA transcripts to be induced by PRB at 6 h after 
initiation of differentiation.   Although we did not find any PRB binding sites within a ±100kb 
window of the VEGF TSS, we identified several binding sites within a ±200kb window. We 
speculate that these regions might be bound by PRB, which then regulates VEGFA expression 
through a looping mechanism. Further research is necessary to understand regulation of VEGFA 
by PRB. 
Lysosomal proteins: One of the most prominent functional categories of genes upregulated by 
PRB was lysosomal proteins, including acid phosphatases, cathepsins, arylsulfatase, lysosomal-
associated membrane proteins, and solute carrier proteins. Changes in lysosomal enzyme 
activities, including increases in acid phosphatase and arylsulfatase B activity during initial 
stages of decidualization were reported previously [44]. These enzymes were maintained in 
lysosomes as progesterone stabilized the lysosomal membranes during decidualization., 
Progesterone withdrawal during menstruation resulted in the release of these enzyme [45].  We 
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believe that future studies will help us understand the roles of these lysosomal enzymes, 
structural lysosomal membrane proteins, and carrier proteins during decidualization and 
pregnancy. 
Apoptosis: According to our gene expression analysis, apoptosis is one of the most prominent 
biological processes regulated by PRA. Apoptosis is normally observed during the menstrual 
cycle. During the early and late proliferative phase, there is little to no apoptosis; by the late 
secretory phase, marked apoptosis is seen and it progresses through most of the functional layer 
of endometrium [46]. Compared to undifferentiated HESCs, differentiating cells were reported to 
be resistant to oxidative stress-induced apoptosis [47], suggesting that resistance to oxidative 
stress might be an acquired feature of decidualized HESC and may be a part of the differentiation 
process itself. Interestingly, we found both negative (BIRC5 and CFLAR) and positive (SMAD3 
and TGFB2) regulators of apoptosis downstream of PRA, suggesting that PRA might be 
involved in regulating the balance of these factors to control apoptosis appropriately in response 
to various internal and external signals. 
Pregnancy specific glycoproteins (PSGs): As mentioned previously, several PSGs were 
upregulated by PRB in our microarray analysis. The PSG proteins are reported to be expressed 
by placental trophoblasts. However, low PSG11 expression in uterine endometrium during the 
peri-implantation period has been correlated with increased risk of pregnancy loss, suggesting 
that PSGs expressed by the endometrium may also have critical functions [48]. Although their 
biological functions are not fully understood, recent studies suggest that these glycoproteins may 
play important immunomodulatory roles to protect the embryo from maternal immune response 
[49]. Additionally, they may be involved in the formation of new vasculature needed for 
successful implantation [50]. We speculate that PSGs may be secreted by decidual cells 
downstream of PRB to regulate the action of cytokines, contribute to immunomodulation, and 
aid in blood vessel formation until trophoblasts take over the PSG production. 
Solute carrier proteins: We found several solute carrier proteins, including monoamine 
transporters, glucose transporters, and ion exchangers downstream of PRB and PRA-PRB co-
expressing cells. These molecules may be critical for monoamine metabolism, which is 
important for regulation of blood flow and capillary permeability [51] and nutrient/ion transport. 
68 
 
Further research is necessary to appreciate the biological roles of these transporter proteins in 
decidualization and reproductive physiology. 
IRS2 signaling: IRS2 was shown previously to be regulated by progesterone [45].  Our study 
confirms these findings and further suggests that IRS2 is a direct target gene of both PRA and 
PRB.  This molecule was of particular interest since IRS2, together with IRS1 and SHC1, is a 
key mediator for the downstream signaling pathways of both insulin and insulin like growth 
factor 1 (IGF-1). The expression and phosphorylation status of IGF system components were 
studied in human decidualization before; both expression and phosphorylation of IRS2 were 
reported to be increased in in vitro decidualized cells [52], suggesting that it might be a critical 
player of the differentiation process. In this study, we showed that both PRA and PRB were 
recruited to the enhancer like regions upstream of IRS2 and increased its expression. 
Importantly, we recognized that IRS2 expression was necessary for human decidualization since 
in vitro differentiation was impaired when IRS2 was silenced.  This finding suggested that IRS2 
might act as a link between insulin/IGF1 and progesterone signaling and potentially implicated 
aberrant IRS2 signaling in reproductive disorders associated with insulin metabolism [52, 53]. 
Our study is unique in terms of identifying cistromes and correlated gene expression 
profiles of PRA and PRB in differentiating human endometrial stromal cells. Our findings 
suggested that PRB was a more potent transcription factor than PRA in human stromal cell 
differentiation in terms of the extent to which it interacts with the genomic binding sites and 
regulates downstream genes. We also found that when PRA and PRB are co-expressed, PRB was 
the prevalent isoform, while PRA was able to influence PRB’s transcriptional activity in some 
cases. This study provided a molecular understanding of some of the known roles of 
progesterone, such as regulation of cell cycle, angiogenesis, and apoptosis. We were also able to 
identify unique target pathways, such as IRS2, downstream of progesterone signaling that is 
likely to play a critical role in pregnancy. 
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FIGURES AND TABLES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.1: Analysis of individual roles of PRA and PRB in differentiating HESC  
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Figure 3.1 cont.: 
A. HESC were either untreated or treated with differentiation cocktail (E+P+cAMP) as 
indicated. Cells were lysed at 24h following treatment, analyzed by SDS-PAGE and subjected to 
Western Blotting using a monoclonal antibody that recognizes both PRA and PRB (kindly 
provided by Dr. Dean Edwards of Baylor College of Medicine) and Calnexin antibody. Calnexin 
immunostaining served as a loading control. Data is representative of five independent 
experiments.  
B. Endogenous PR was depleted in HESC by transfecting the cells with siRNA targeted to 
the 3’-untranslated region (UTR) of the PGR mRNA for 24h. Next, cells were transduced with 
adenovirus harboring flag-tagged PRA or PRB cDNA without the 3’ UTR or a control virus 
carrying the empty vector for 24h. This strategy allowed the reconstitution of PRA or PRB 
expression in the HESC and created conditions under which the biological activity of either PRA 
or PRB can be tested independently. 
C. HESC were treated with 50nM control siRNA or siRNA targeting 3’UTR of PR mRNA. 
Next, cells were transduced with adenovirus harboring flag-tagged PRA or PRB or control virus 
for 24h. Whole cell lysates were prepared from these cells. For each sample, 30μg of whole cell 
lysate was analyzed by western blotting using a monoclonal antibody that recognizes both PRA 
and PRB. Immunostaining of calnexin was used as a loading control. 
D. HESC were treated with 50nM control siRNA or siRNA targeting 3’UTR of PR mRNA. 
Next, cells were transduced with adenovirus harboring flag-tagged PRA or PRB or control virus 
for 24h. Then, siRNA and adenovirus were removed and cells were treated with differentiation 
cocktail. Total RNA was isolated at 60 h after differentiation cocktail addition and cDNAs were 
prepared. cDNAs were subjected to real-time PCR using gene specific primers for PR, PRL, and 
IGFBP1. PCR data are normalized to 36B4 mRNA levels. Relative fold changes were 
normalized with respect to control siRNA treatment. 
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Figure 3.2: Genome-wide PRA and PRB binding locations in differentiating HESC 
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Fig. 3.2 cont.: 
A. ChIP-seq PRA and PRB binding site counts. Venn diagrams of the intersection of multiple 
intervals files between PRA vs. PRB binding sites with fdr<5% cut off. 
B. A subset of progesterone receptor binding sites identified in the ChIP-seq experiment was 
selected for validation. ChIP was performed as described in materials and methods section. 
Chromatin enrichment was quantified by real-time PCR using primers flanking these 
potential binding sites on different chromosomes as indicated in the figure. Negative region 
was a PRE deficient region. To calculate the enrichment of chromatin, the resulting signals 
were normalized to 1% input DNA. Data are represented as fold enrichment over that of the 
negative control ChIP. Data is representative of three independent experiments. 
C. Binding site- genomic region association of genome-wide PRA and PRB binding sites. 
CEAS: Enrichment on chromosome and annotation tool of Cistrome was used to analyze the 
distribution of binding sites with the following parameters: promoter/downstream -lower 
interval: 2500, -middle interval: 5000, - upper interval: 1000, bi-promoter -lower range: 
5000, -upper range: 10000, relative distance: 5000. 
D. UCSC Genome Browser illustration of the localization of PRB binding site in PGR gene.  
E. ChIP-RT-qPCR validation of PRB binding in the first exon of PGR gene. ChIP was 
performed as described in materials and methods section. Chromatin enrichment was 
quantified by RT- PCR using primers flanking PRB binding site in the PRA promoter region. 
Negative region was a PRE deficient region. To calculate the enrichment of chromatin, the 
resulting signals were normalized to 1% input DNA. Data are represented as fold enrichment 
of PRA or PRB binding over that of the negative control ChIP. Data is representative of three 
independent experiments. 
F. HESC were transduced with increasing MOIs of adenovirus harboring PRA or PRB for 24h, 
control sample was not transduced. Next, cells were treated with differentiation cocktail for 
6h. Whole cell protein extracts were prepared from these cells and analyzed by western 
blotting using a monoclonal antibody that recognizes both PRA and PRB (kindly provided by 
Dr. Dean Edwards of Baylor College of Medicine). Immunostaining of calnexin was used as 
a loading control. 
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Figure 3.3: Motif analysis 
A. PRE progesterone receptor binding motif for PRA and PRB identified by de novo motif 
analysis using Seqpos tool of Cistrome [22]. 
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Figure 3.3 cont.: 
B. Relative position of PRE within the summits of the binding sites was identified using 
MEME-ChIP [21]. 
C. Comparison of identified motifs within the 200nt window of PRA PRB binding sites. 
HESC were subjected to treatment with differentiation cocktail for 48h. CEBPB ChIP was 
performed as described in material and methods. Chromatin enrichment was quantified by real-
time PCR using primers flanking the CEBPB motif containing PRA and PRB binding sites 
(chr20 pre, chr1 pre, chr2 pre) and CEBPB motif negative PRB binding site (chr11 pre) as 
indicated in the figure. To calculate the enrichment of chromatin, the resulting signals were 
normalized to 1% input DNA. Data are represented as fold enrichment of CEBPB binding over 
that of the mock IgG ChIP. Graphs represent the mean ± SD of three independent experiments.  
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Table 3.1: List of motifs observed in the 200nt sequence around the summits of PRA 
binding sites 
  
factors DNA binding domain consensus hits zscore 
-
10*log(p
val) 
1 de novo** None 2AC4TGT2 3686 -49.89 1.00E-30 
2 
NR3C1 
(GR)** Hormone-nuclear Receptor Family 1G1AC5GT4 3626 -48.89 1.00E-30 
3 de novo** None 5ACA4GT2 3856 -48.67 1.00E-30 
4 PGR** Hormone-nuclear Receptor Family G1AC5GT2 2919 -48.63 1.00E-30 
5 AR** Hormone-nuclear Receptor Family 3AC5GT1C2 3730 -47.59 1.00E-30 
6 de novo** None 4ACA4GT6 3196 -46.37 1.00E-30 
7 de novo** None GAACAKWMTG 2857 -37.72 1.00E-30 
8 de novo* None MAGAACA 3696 -27.18 1.00E-30 
9 de novo* None CAGAACATTY 4020 -23.99 1.00E-30 
10 de novo* None RVMMAGAACA 2598 -23.71 1.00E-30 
11 de novo* None CTGTSCT 3810 -20.78 1.00E-30 
12 Rest BetaBetaAlpha-zinc finger Family  3A2AC3G3A3 243 -17.03 1.00E-30 
13 de novo None CCAWGGACAG 375 -15.84 1.00E-30 
14 de novo* None TSTGTTY 2482 -13.24 1.00E-30 
15 de novo None AARSACA 3109 -13.16 1.00E-30 
16 Snai1 BetaBetaAlpha-zinc finger Family 6CTG1CC1 186 -10.42 9.88E-26 
17 de novo* None YTCTGTSCTB 3729 -10.18 1.21E-24 
18 de novo None MRGAATG 2510 -8.90 2.72E-19 
19 de novo* None T1TGT2T5 4397 -8.71 1.51E-18 
20 Jun Leucine zipper Family (bZIP) ATGASTCAG 1844 -8.52 7.65E-18 
21 NR1H4 Hormone-nuclear Receptor Family AGGWCAT 2709 -8.48 1.15E-17 
22 Gm5454 Ets Domain Family 4C2GA1GT4 3213 -8.42 1.86E-17 
23 ZBTB12 BetaBetaAlpha-zinc finger Family 6T1GAAC5 3985 -8.37 2.93E-17 
24 Esr1 Hormone-nuclear Receptor Family 5CA3TG1C2 4269 -7.99 6.80E-16 
25 Etv5 Ets Domain Family 4C1GGA1G5 4017 -7.93 1.11E-15 
26 Elk3 Ets Domain Family 5C1GGAA6 4146 -7.68 7.70E-15 
27 ZNF205 BetaBetaAlpha-zinc finger Family SARAATG 1527 -7.61 1.33E-14 
28 NR4A1 Hormone-nuclear Receptor Family YTGWCCTTKB 4511 -7.25 2.07E-13 
29 ESR2 Hormone-nuclear Receptor Family 9CA3TG1C2 4914 -7.17 3.69E-13 
30 Nkx3-1 Homeodomain Family 2TRTKT6 3726 -7.14 4.67E-13 
31 NR4A2 Hormone-nuclear Receptor Family AAGRWCAV 4911 -7.09 6.71E-13 
32 NR2C2 Hormone-nuclear Receptor Family 
SARAGKWCAG
R 4596 -6.79 5.66E-12 
33 ELK4 Ets Domain Family 4C1GGAA6 3838 -6.70 1.05E-11 
34 HSF1 Transcription Factor Family MTGGAACA 3421 -6.69 1.15E-11 
35 FOSL2 Leucine zipper Family (bZIP) TGACTCA 2416 -6.65 1.46E-11 
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36 JUND Leucine zipper Family (bZIP) TGAGTCAY 2486 -6.46 5.16E-11 
37 SOX10 
High Mobility Group (Box) 
Family ACAMWG 3007 -6.21 2.70E-10 
38 JUNB Leucine zipper Family (bZIP) MTGASTCAYM 2144 -5.83 2.77E-09 
39 Zfp691 BetaBetaAlpha-zinc finger Family 5AGT1CT6 4301 -5.58 1.20E-08 
40 NFE2 Leucine zipper Family (bZIP) 
WRMTGASTCA
Y 1902 -5.54 1.48E-08 
41 BACH2 Leucine zipper Family (bZIP) 
VRTGAGTCAT
M 2512 -5.48 2.07E-08 
42 HIF1A Helix-Loop-Helix Family (bHLH) MDKCACGTHY 3079 -5.37 3.93E-08 
43 BACH1 Leucine zipper Family (bZIP) 4T1AGT1A4 1446 -5.34 4.59E-08 
44 NKX2-3 Homeodomain Family 4AAG2CT5 2905 -5.32 5.13E-08 
45 FOSL1 Leucine zipper Family (bZIP) RTGASTCABM 2277 -5.30 5.66E-08 
46 Tbx21 Transcription Factor T-Domain RTGASTCAKM 2351 -5.16 1.22E-07 
47 Nr5a2 Hormone-nuclear Receptor Family TGDCCTTGRR 2508 -5.14 1.38E-07 
48 Jund Leucine zipper Family (bZIP) 8TGA1T1A1 1611 -5.06 2.06E-07 
**similar to PRE (progesterone response element) 
*similar to half PRE 
 
Table 3.1 cont.:  
De novo motif analysis was performed on 200nt sequences around summits of top 5000 PRA 
binding sites using SeqPos tool of Cistrome. Motifs are sorted by z-score with a cut off value of -
5. 
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Table 3.2: List of motifs observed in the 200nt sequence around the summits of PRB 
binding sites 
 
factors DNA binding domain consensus hits zscore 
-
10*log(p
val) 
1 de novo** None 2AC4TGT2 4824 -67.52 1.00E-30 
2 de novo** None 2G1AC5GT3 4827 -66.67 1.00E-30 
3 NR3C1 
(GR)** 
Hormone-nuclear Receptor Family 1G1AC5GT4 4313 -65.81 1.00E-30 
4 AR** Hormone-nuclear Receptor Family 3AC5GT1C2 4535 -64.33 1.00E-30 
5 PGR** Hormone-nuclear Receptor Family G1AC5GT2 4671 -64.23 1.00E-30 
6 de novo** None 3ACA5T1C5 4600 -56.38 1.00E-30 
7 de novo* None CAKWMTGTTC 4120 -50.47 1.00E-30 
8 de novo* None 3CTGT1C4 4746 -40.16 1.00E-30 
9 de novo* None MTGTTCY 3387 -39.00 1.00E-30 
10 de novo* None MTGTYCT 4934 -38.70 1.00E-30 
11 de novo* None TGTTCTG 3695 -36.42 1.00E-30 
12 de novo* None WMTGTYCTKK 3611 -36.07 1.00E-30 
13 de novo* None TGTTCTKKKY 2777 -35.11 1.00E-30 
14 de novo* None T2TGT1C8 4547 -26.93 1.00E-30 
15 de novo None WRRAMWGTK
Y 
4965 -24.90 1.00E-30 
16 de novo* None TGT1CT7 4237 -23.33 1.00E-30 
17 de novo* None TGTVYTT 3650 -20.33 1.00E-30 
18 de novo None GAATGTR 2810 -17.76 1.00E-30 
19 de novo None CAGRAWG 4634 -16.81 1.00E-30 
20 de novo None CATBCTSTCC 3471 -16.20 1.00E-30 
21 de novo None TMCAGAA 4933 -15.86 1.00E-30 
22 de novo None SMCAGRA 4839 -14.58 1.00E-30 
23 Elk3 Ets Domain Family 6TTCC1G5 4943 -13.46 1.00E-30 
24 NR1H4 Hormone-nuclear Receptor Family AGGWCAT 3160 -13.42 1.00E-30 
25 Gm5454 Ets Domain Family 4AC1TC2G4 4628 -13.39 1.00E-30 
26 Etv5 Ets Domain Family 5C1TCC1G4 4524 -13.35 1.00E-30 
27 ESR2 Hormone-nuclear Receptor Family 9CA3TG1C2 4960 -12.77 1.00E-30 
28 ZBTB12 BetaBetaAlpha-zinc finger Family 5C2GAAC5 4151 -12.73 1.00E-30 
29 Esr1 Hormone-nuclear Receptor Family 5CA3TG1C2 4320 -12.28 1.00E-30 
30 ELK4 Ets Domain Family 6TTCC1G4 4726 -12.09 1.00E-30 
31 HSF1 Transcription Factor Family MTGGAACA 4428 -11.78 1.00E-30 
32 Rest BetaBetaAlpha-zinc finger Family  3T1T1C4T2T3 127 -11.71 1.00E-30 
33 ZNF205 BetaBetaAlpha-zinc finger Family SARAATG 1587 -11.69 1.00E-30 
35 HSF2 Transcription Factor Family TT5A2TT1 1941 -11.23 1.50E-29 
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Table 3.2 cont. 
36 PAX6 Homeodomain Family 3T3AG2CA1 3115 -10.97 2.72E-28 
38 NR2C2 Hormone-nuclear Receptor Family SARAGKWCWG
D 
4418 -10.53 3.28E-26 
39 REST BetaBetaAlpha-zinc finger Family  7CT1TCC3 212 -10.12 2.23E-24 
41 NR4A2 Hormone-nuclear Receptor Family BTGWYCTT 4979 -10.05 4.42E-24 
42 Hsf1 Transcription Factor Family 6C2G4TTC2 2693 -9.78 6.81E-23 
43 Spdef Ets Domain Family 5TCCKG6 4964 -9.54 7.48E-22 
44 SOX10 High Mobility Group (Box) 
Family 
CWKTGT 4962 -9.46 1.50E-21 
45 PAX1 Homeodomain Family CWGGAACWM
AM 
4955 -9.27 9.71E-21 
46 ETV4 Ets Domain Family 4A2TCC1G4 4947 -8.78 7.92E-19 
47 ETV1 Ets Domain Family ACAGGAART 406 -8.27 6.79E-17 
48 Tead4 Homeodomain Family 6GGAAT2 864 -8.02 5.16E-16 
49 MTF1 BetaBetaAlpha-zinc finger Family 1T4A4TTT6 2790 -7.72 5.77E-15 
50 HSF1 Transcription Factor Family 2C2G1A3TC 4706 -7.57 1.86E-14 
51 Trp63 Loop-Sheet-Helix Family (bHSH) 6G5AC1TG3 4139 -7.52 2.67E-14 
52 Fli1 Ets Domain Family ACAGGAART 441 -7.41 6.54E-14 
53 Hnf4a Hormone-nuclear Receptor Family 4CT1TG2C4 4212 -7.21 2.76E-13 
54 IKZF1 BetaBetaAlpha-zinc finger Family 3RTTCC5 4392 -7.17 3.74E-13 
55 EPAS1 Leucine zipper Family (bZIP) RWACGTGMYK 4986 -7.16 4.03E-13 
56 HIF1A Helix-Loop-Helix Family (bHLH) RDACGTGMHK 3183 -7.15 4.38E-13 
57 ELF2 Ets Domain Family 6TTCC1G4 4045 -7.15 4.41E-13 
59 NKX2-3 Homeodomain Family 5AG2CTT4 653 -6.78 5.86E-12 
60 Zfp187 BetaBetaAlpha-zinc finger Family 3TT4CAT2 2195 -6.50 4.07E-11 
61 Zfp691 BetaBetaAlpha-zinc finger Family 6AG1ACT5 4989 -6.49 4.36E-11 
62 de novo None CWGGRAG 4167 -6.47 4.79E-11 
63 Zfp128 BetaBetaAlpha-zinc finger Family 5K1C1TAC5 4130 -6.28 1.67E-10 
64 Ikzf3 BetaBetaAlpha-zinc finger Family  YWYTTCCTSY 4842 -6.19 3.02E-10 
65 SOX13 High Mobility Group (Box) 
Family 
5AACAA6 4757 -6.11 5.04E-10 
66 Stat5b Stat Protein Family TTCYARGAAA 2509 -6.06 6.93E-10 
67 ESR1 Hormone-nuclear Receptor Family 1K2C4TG1C3 4988 -5.92 1.62E-09 
68 Ets1 Ets Domain Family 3C1TCCT4 4147 -5.84 2.60E-09 
69 Snai1 BetaBetaAlpha-zinc finger Family 6CTGT1C1 4228 -5.75 4.36E-09 
70 TEF Leucine zipper Family (bZIP) VWSWGGAATG
TR 
2381 -5.72 5.33E-09 
71 TEAD1 Homeodomain Family VWSWGGAATG
TR 
2381 -5.64 8.61E-09 
72 MTF1 BetaBetaAlpha-zinc finger Family 4T1CACA6 4985 -5.63 9.23E-09 
73 Elf4 Ets Domain Family 6TTCC1G4 4945 -5.50 1.89E-08 
74 CEBPB Leucine zipper Family (bZIP) 1TK3CAA4 479 -5.37 3.98E-08 
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75 Cebpa Leucine zipper Family (bZIP) 4TT1C2MA1 906 -5.28 6.49E-08 
76 Irx3 Homeodomain Family 5ACATG7 4988 -5.23 8.46E-08 
77 SOX5 High Mobility Group (Box) 
Family 
5AACAA6 2924 -5.15 1.33E-07 
78 NR4A1 Hormone-nuclear Receptor Family YTGWCCTTKB 935 -5.07 1.97E-07 
79 CEBPA Leucine zipper Family (bZIP) 3TT3CAA2 621 -5.07 2.03E-07 
80 CEBPE Leucine zipper Family (bZIP) RTKWYRCAAY 829 -5.06 2.08E-07 
**similar to PRE (progesterone response element) 
*similar to half PRE 
 
Table 3.2 cont.: 
De novo motif analysis was performed on 200nt sequences around summits of top 5000 PRB 
binding sites using SeqPos tool of Cistrome. Motifs are sorted by z-score with a cut off value 
of -5. 
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Figure 3.4: Gene networks downstream of PRA, PRB, or PRA & PRB co-expressing HESC 
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Figure 3.4 cont.: 
A. Venn diagram represents the number and overlap of the PRA regulated genes with that of 
PRB regulated genes. 
B. Venn diagram represents the number and overlap of the PRA regulated genes with that of 
PRA-PRB co-regulated genes 
C. Venn diagram represents the number and overlap of the PRB regulated genes with that of  
PRA-PRB co-regulated genes 
D. Venn diagram represents the number and overlap of the PRA upregulated and downregulated 
genes with list of genes with PRA binding sites within a window of ±100kb from their TSS. 
E. Venn diagram represents the number and overlap of the PRB upregulated and downregulated 
genes with list of genes with PRB binding sites within a window of ±100kb from their TSS.  
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Table 3.3: Functional Annotation Clustering of PRA regulated genes 
Functional annotation clustering of PRA upregulated genes 
Clu
ster  
Enrichment 
Score 
Category Representative Term Count % PValue 
1 6.82 GOTERM_BP_FAT Regulation of apoptosis 43 14.63 1.26E-07 
2 5.76 GOTERM_BP_FAT Negative regulation of apoptosis 25 8.50 1.47E-06 
3 3.67 GOTERM_BP_FAT 
Protein amino acid 
phosphorylation 
31 10.54 5.88E-05 
4 3.41 GOTERM_BP_FAT Regulation of angiogenesis 17 5.78 1.83E-04 
5 3.17 GOTERM_BP_FAT Cell death 31 10.54 3.66E-04 
6 3.12 GOTERM_BP_FAT Positive regulation of apoptosis 22 7.48 7.08E-04 
7 3.10 GOTERM_BP_FAT Regulation of cell motion 14 4.76 5.43E-04 
8 3.08 UP_SEQ_FEATURE Protein kinase 22 7.48 2.34E-04 
9 2.92 GOTERM_BP_FAT 
Positive regulation of cell 
motion 
10 3.40 5.47E-04 
10 2.89 GOTERM_BP_FAT 
Branching morphogenesis of a 
tube 
8 2.72 7.96E-04 
11 2.84 GOTERM_BP_FAT 
Regulation of adaptive immune 
response based on somatic 
recombination of immune 
receptors built from 
immunoglobulin superfamily 
domains 
8 2.72 2.08E-04 
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Functional annotation clustering of PRA downregulated genes 
Clu
ster  
Enrichm
ent 
Score 
Category Representative Term Count % PValue 
1 2.90 SP_PIR_KEYWORDS Transcription 37 20.33 4.87E-04 
2 2.06 GOTERM_MF_FAT Translation elongation factor 
activity 
4 2.20 0.002774
801 
3 1.55 GOTERM_BP_FAT Cellular cation homeostasis 10 5.49 0.008326
236 
 
 
Table 3.3 cont.: 
The DAVID gene functional annotation tool was used for the gene-GO term enrichment 
analysis of PRA regulated genes. The upregulated and downregulated genes were classified 
separately into the different GO FAT terms (Biological Process) with high classification 
stringency. 
  
91 
 
Table 3.4: Functional Annotation Clustering of PRB regulated genes 
Functional annotation clustering of PRB upregulated genes 
 
Cluster  
Enrichment 
Score 
Category Representative Term Count % PValue 
1 10.39 GOTERM_CC_FAT Lysosomal proteins 44 4.28 
2.35E-
10 
2 6.89 
UP_SEQ_FEATUR
E 
Transmembrane region 
proteins 
324 31.49 
2.97E-
09 
3 6.23 GOTERM_BP_FAT Regulation of angiogenesis 44 4.28 
3.41E-
07 
4 6.09 GOTERM_BP_FAT 
Response to extracellular 
stimulus 
38 3.69 
1.54E-
06 
5 5.71 GOTERM_BP_FAT Regulation of cell motion 36 3.50 
1.02E-
06 
6 5.11 SMART Histone core H2B 8 0.78 
5.76E-
06 
7 4.66 GOTERM_BP_FAT Regulation of apoptosis 92 8.94 
1.58E-
05 
8 4.25 GOTERM_BP_FAT Nucleosome assembly 17 1.65 
1.92E-
05 
9 4.09 GOTERM_BP_FAT Cell death 79 7.68 
7.45E-
05 
10 3.74 GOTERM_BP_FAT 
Positive regulation of cell 
migration 
19 1.85 
1.76E-
04 
11 3.68 
SP_PIR_KEYWOR
DS 
Egf-like domain 31 3.01 
1.49E-
04 
12 3.67 
GOTERM_MF_FA
T 
Insulin-like growth factor 
binding 
10 0.97 
2.48E-
05 
13 2.86 GOTERM_BP_FAT Regulation of cell migration 37 3.60 
5.42E-
04 
14 2.86 GOTERM_BP_FAT 
Positive regulation of cell 
death 
51 4.96 
0.00106
9 
15 2.60 GOTERM_BP_FAT 
Regulation of phosphate 
metabolic process 
53 5.15 
0.00201
9 
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Functional annotation clustering of PRB downregulated genes 
 
Cluster  
Enrichment 
Score 
Category Representative Term Count % PValue 
1 56.30 GOTERM_BP_FAT Cell cycle phase 120 16.51 
6.28E-
62 
2 51.02 GOTERM_BP_FAT M phase 106 14.58 
1.81E-
61 
3 21.65 GOTERM_CC_FAT Kinetochore 32 4.40 
5.09E-
22 
4 17.83 GOTERM_CC_FAT Nuclear lumen 152 20.91 
2.59E-
22 
5 16.96 GOTERM_CC_FAT Microtubule cytoskeleton 88 12.10 
4.25E-
27 
6 10.11 GOTERM_BP_FAT M phase of meiotic cell cycle 23 3.16 
6.36E-
11 
7 10.06 GOTERM_BP_FAT DNA repair 46 6.33 
1.52E-
12 
 
Table 3.4 cont.: 
The DAVID gene functional annotation tool was used for the gene-GO term enrichment 
analysis of PRB regulated genes. The upregulated and downregulated genes were classified 
separately into the different GO FAT terms (Biological Process) with high classification 
stringency. 
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Table 3.5: Functional Annotation Clustering of PRA+PRB regulated genes 
Functional annotation clustering of PRA+PRB upregulated genes 
Cluster  Enrichment 
Score 
Category Representative Term Count % PValue 
1 9.03 GOTERM_CC_FAT 
Lysosomal proteins 
41 4.13 3.07E-
09 
2 6.62 GOTERM_CC_FAT 
Transmembrane region proteins 
339 34.1
7 
3.83E-
06 
3 4.06 INTERPRO Histone core H2B 7 0.71 8.15E-
05 
4 3.97 GOTERM_BP_FAT Regulation of cell migration 29 2.92 4.94E-
05 
5 3.76 GOTERM_MF_FAT Insulin-like growth factor 
binding 
10 1.01 2.16E-
05 
6 3.41 GOTERM_CC_FAT Nucleosome 15 1.51 1.56E-
05 
7 3.28 GOTERM_MF_FAT Endopeptidase activity 42 4.23 1.61E-
04 
8 3.17 GOTERM_BP_FAT Cell death 74 7.46 4.23E-
04 
9 2.92 GOTERM_BP_FAT Response to nutrient levels 29 2.92 4.30E-
04 
10 2.22 KEGG_PATHWAY Chondroitin sulfate biosynthesis 8 0.81 5.78E-
04 
11 2.22 GOTERM_BP_FAT Positive regulation of phosphate 
metabolic process 
16 1.61 0.0034
87 
12 2.18 GOTERM_BP_FAT Regulation of apoptosis 77 7.76 0.0060
42 
13 2.11 GOTERM_MF_FAT Serine-type endopeptidase 
activity 
19 1.92 0.0040
4 
14 2.03 GOTERM_BP_FAT Aminoglycan metabolic process 11 1.11 0.0043
28 
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Functional annotation clustering of PRA+PRB downregulated genes 
Cluster  Enrichment 
Score 
Category Representative Term Count % PValue 
1 55.58 GOTERM_BP_FAT Cell cycle phase 112 16.77 3.08E-
58 
2 46.37 GOTERM_BP_FAT M phase 98 14.67 1.26E-
56 
3 40.40 SP_PIR_KEYWORDS Cell division 75 11.23 3.38E-
42 
4 22.44 GOTERM_CC_FAT Nuclear lumen 155 23.20 9.90E-
28 
5 21.99 GOTERM_CC_FAT Kinetochore 32 4.79 4.86E-
23 
6 16.96 GOTERM_CC_FAT Microtubule cytoskeleton 85 12.72 1.70E-
27 
7 11.78 GOTERM_BP_FAT M phase of meiotic cell cycle 24 3.59 1.34E-
12 
8 8.85 UP_SEQ_FEATURE Nucleotide phosphate-
binding region:ATP 
88 13.17 3.63E-
12 
 
Table 3.5 cont.:  
The DAVID gene functional annotation tool was used for the gene-GO term enrichment 
analysis of differentially regulated genes in PRA+PRB co-expressing cells. The upregulated 
and downregulated genes were classified separately into the different GO FAT terms 
(Biological Process) with high classification stringency. 
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Figure 3.5: Validation of PRB regulation of cell cycle and angiogenesis related molecules  
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Figure 3.5 cont.:   
A. HESC were treated with 50nM control siRNA or siRNA targeting 3’UTR of PGR mRNA. 
Next, cells were transduced with adenovirus harboring flag-tagged PRA or PRB or control 
virus for 24h. Then, siRNA and adenovirus were removed and cells were treated with 
differentiation cocktail. Total RNA was isolated at 6h and cDNAs were prepared. cDNAs 
were subjected to real-time PCR using gene specific primers for CCNA2, CCNB1, CDC20, 
CDC25A, CDK1 and 36B4. PCR data are normalized to 36B4 mRNA levels. Relative fold 
changes were normalized with respect to control siRNA treatment. Graphs represent the 
mean ± SEM of three independent experiments. One-way ANOVA was used for statistical 
analysis; p≤0.05*, p≤0.01**. 
B. Same samples were used to run real time PCR using gene specific primers for ANGPTN1, 
ANGPTNL4 and VEGFA. Graphs represent the mean ± SEM of three independent 
experiments. One-way ANOVA test was used for statistical analysis; p≤0.05*, p≤0.01**. 
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Figure 3.6: IRS2 is regulated by PRA and PRB and critical for stromal differentiation 
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Figure 3.6 cont.: 
A. HESC were transduced with or without recombinant adenovirus harboring flag-tagged PRA 
or PRB for 24 h. Then, samples were subjected to treatment with differentiation cocktail for 
2 h. ChIP was performed as described in material and methods. Chromatin enrichment was 
quantified by real-time PCR using primers flanking potential PRA and PRB binding sites in 
the 5’-flanking region of IRS2 at -88kb and -307kb. The experiment was repeated three times 
and representative data are shown. 
B. HESC were treated with 50nM control siRNA or siRNA targeting 3’UTR of PGR mRNA. 
Next, cells were transduced with adenovirus harboring flag-tagged PRA or PRB or control 
virus for 24h. Then, siRNA and adenovirus were removed and cells were treated with 
differentiation cocktail. Total RNA was isolated at 24h after differentiation cocktail addition 
and cDNAs were prepared. cDNAs were subjected to real-time PCR using gene specific 
primers for IRS2. PCR data are normalized to 36B4 mRNA levels. Relative fold changes 
were normalized with respect to basal levels of IRS2 before differentiation cocktail addition 
indicated as 0h in the figure. Experiment was performed two times and representative data 
are shown. 
C.  HESCs were transfected with siRNA targeting IRS2 or scrambled siRNA (control). 48h after 
transfection, HESCs were treated with differentiation cocktail to initiate in vitro 
differentiation. Cells were harvested at 72h following differentiation cocktail treatment. Total 
RNA was isolated and cDNAs were prepared. cDNAs were subjected to  real-time PCR 
using gene specific primers for IRS2, PRL , IGFBP1 and WNT4. PCR data are normalized to 
36B4 mRNA levels. Relative fold changes were normalized with respect to control non-
targeting siRNA treatment. Graphs represent the mean ± SD of three independent 
experiments (p≤0.05*).
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Fig. 3.7: Interaction of a distal and a proximal progesterone receptor binding site of  a PRB 
target gene, PSG4 
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Fig. 3.7 cont.:  
Chromosome conformation capture assay (3C) was performed  using HESC were untreated or 
transduced with adenovirus harboring PRA and PRB cDNA. At 24h, cells were untreated or 
treated with differentiation cocktail for 30 min as indicated in the figure. 3C was performed as 
explained elsewher [54]. A.UCSC genome browser snapshot showing the locations of PRB 
binding sites scattered around  PSG genes. B. ChIP-qPCR validation of PRB binding in the 
intron and enhancer-like upstream region of PSG4 gene. ChIP was performed as described in 
materials and methods section. Chromatin enrichment was quantified by RT- PCR. Negative 
region was a PRE deficient region. To calculate the enrichment of chromatin, the resulting 
signals were normalized to 1% input DNA. Data are represented as fold enrichment of PRA or 
PRB binding over that of the negative control ChIP. Data is representative of two independent 
experiments. C. Upper panel: Illustration of PRB binding sites and localization of 3C primers. 
Lower panel: 3C PCR results. This experiment was performed once. Primer pair 1&2 were 
designed to amplify a genomic region free of restriction enzyme digestion sites as a loading 
control between the samples. Primer pair 2&3 would amplify a product  (~140bp)  as a result of 
an  intermolecular ligation of the proximal and distal PRB binding sites.  
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CHAPTER IV 
CONCLUSIONS AND FUTURE PERSPECTIVES 
 
ESR1 plays a critical role in human decidualization  
To improve our understanding of the molecular mechanisms controlling uterine 
decidualization and better address the underlying causes of various endometrial disorders, it is 
important to extend the information gained from the mouse models to the clinical realm. In our 
laboratory, we developed several conditional knockout mouse models to address the functional 
roles of a variety of maternal factors, such as transcription factors, cytokines, morphogens, etc., 
during early pregnancy. A major focus of our laboratory is to use primary cultures of human 
endometrial cells to examine in parallel the roles of these molecules in the human.  
 One of the main objectives of my project was to address the role of estrogen receptor 
alpha during endometrial stromal differentiation in the human. Previously, our laboratory 
developed conditional knockout mice in which the “floxed” Esr1 gene was deleted in the uterine 
epithelial and stromal cells by a progesterone receptor (PR)-driven Cre. This genetically altered 
mouse model showed that the expression of estrogen receptor alpha (ESR1) in the uterus is 
essential for proper differentiation of the endometrium (Mary J. Laws, Milan K. Bagchi and 
Indrani C. Bagchi, unpublished data). However, since Esr1 was deleted in both epithelial and 
stromal cells, it was not possible to distinguish between the stromal versus epithelial functions of 
ESR1 in decidualization. In the present study, we used primary human endometrial stromal cells 
to examine the role of ESR1 in human uterine differentiation. Silencing of ESR1 expression by 
RNA interference increased stromal cell proliferation and inhibited differentiation. We showed 
that ESR1 suppressed a number of key cell cycle regulatory molecules so that the stromal cells 
could cease to proliferate and were able to enter the differentiation program. There were many 
similarities in downstream gene networks regulated by ESR1 in the mouse and the human. These 
included factors involved in hepatocyte growth factor signaling, growth hormone signaling, 
polo-like kinase signaling and regulation of the cell cycle. Down regulation of ESR1 expression 
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in human endometrial stromal cells impaired the expression of PR, WNT4, and FOXO1, which 
are known regulators of the stromal differentiation process in mice. Our studies, therefore, 
established a critical and conserved role of ESR1 during decidualization in the human.  
We also observed that, during stromal differentiation, ESR1 acts in concert with cAMP 
signaling to modulate target gene expression. Our studies revealed that the mediator complex 
(MED1), a critical transcription co-regulatory factor, is modified by phosphorylation by cAMP-
dependent PKA and serves as a link between ESR1 and the basal transcription machinery to 
promote target gene transcription. We, however, do not rule out that additional factors may 
interact with ESR1 and modulate its transcriptional activity. 
The finding that ESR1 suppresses the proliferation of endometrial stromal cell during 
decidualization was surprising. Estrogen generally induces cell proliferation in tissues, such as 
the uterine and mammary epithelia.  However, there are scenarios where estrogen suppresses cell 
cycle progression. For instance, estrogen treatment induces proliferation of human MCF7 breast 
tumor cells while it represses proliferation of MDA-MB-231 tumor cells [1]. The difference in 
its proliferative response in different cell types may be due to inherent differences in the 
composition, levels, and activities of various signaling molecules, transcription factors and 
cofactors. This concept is supported by a previous report that the antiestrogen ICI 182780 has no 
inhibitory effect on proliferation of certain immortalized endometrial cells [2]. In fact, it exerts a 
stimulatory effect at low concentrations. Collectively, these findings suggest that targeting of 
ESR1 for alleviation of endometrial stromal tumors may be ineffective or even have an 
unfavorable consequence.  A clear understanding of the mechanisms that control endometrial 
growth and differentiation is important for developing effective treatment strategies for 
endometrial diseases. 
Role of PR isoforms in human decidualization 
It is well established that P is the most important regulator of stromal differentiation in 
both mice and humans. Female mice lacking the PRA isoform are infertile and present with 
several reproductive abnormalities, including loss of uterine receptivity and impaired stromal 
decidualization [3-5]. On the other hand, PRB-null mice are fertile and retain normal 
decidualization response [6]. To address the specific roles of PRA and PRB in human 
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decidualization, we independently expressed PRA and PRB in human stromal cell cultures. Our 
findings, summarized in Chapter III, suggest that, unlike what was observed in mice, PRB is a 
more potent transcriptional regulator than PRA during human stromal cell differentiation. We 
determined that PRB interacted with and regulated many more target genes than PRA. We also 
found that when the two isoforms are co-expressed, the PRB activity is predominant.  
Many human endometrial disorders, such as endometriosis and endometrial cancer, are 
associated with altered PRA:PRB ratio. For example, in ectopic endometriotic tissue, PRA, but 
no PRB protein, is detected [7]. This suppression of PRB expression in endometriosis was linked 
to the hypermethylation of its promoter [8]. Differential expression of PR isoforms was also 
reported in endometrial cancer. Whereas well-differentiated cancer cells (Ishikawa) expressed 
both PRA and PRB, the poorly differentiated cancer cells (HecSO and KLE) expressed only 
PRA [9]. One of the well-established roles of P signaling in the endometrium is suppression of 
cell proliferation [10]. Our study suggested that PRB inhibited proliferation of stromal cells by 
suppressing the expressions of key cell cycle regulators, including CCNB1, CDK1 and CDC20, 
while PRA did not affect their expression. We believe that this finding is critical for 
understanding endometrial disorders, such as endometrial cancers and endometriosis, and 
reduced expression of PRB may be a critical predictive marker for cancers that are unresponsive 
to progestin therapy. 
Identification of potential direct targets of PRA and PRB during human decidualization 
Using ChIP-seq analysis, we identified a large number of genes as potential targets of 
regulation by PRA and PRB during decidualization of human endometrial stromal cells. 
Prominent among these genes is the transcription factor HAND2 (heart- and neural crest 
derivatives-expressed protein 2), which was previously shown to be required for implantation 
and decidualization in the mouse [11]. Our laboratory is currently analyzing the functions of the 
PRA and PRB binding sites in regulation of HAND2 expression during various phases of the 
implantation process. BMP2 (bone morphogenetic protein 2) was also reported to be downstream 
of P and required for differentiation of stromal cells in both mice and human [12, 13]. We 
identified a PRB binding site in the regulatory region of this gene, suggesting that P regulation of 
BMP2 might be via direct binding of this site by PRB. We also identified HOXA10 and HOXA11 
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as potential direct targets of PRB. These transcription factors, which belong to the Hox family of 
genes, are required for successful pregnancy in mice [14, 15]. The P-regulated expression of 
HOXA10 and HOXA11 occurs in human endometrium within the window of implantation [16, 
17]. We identified several other critical regulators of stromal differentiation, such as KLF4, 
KLF9, and STAT3, as potential direct targets of PRA and PRB. These findings provided an 
understanding of the conserved molecular pathways by which P, acting via its receptors, 
regulates decidualization in the mouse and the human. In addition, several other factors, 
identified as PR target genes in our study, may have as yet unknown functions during 
decidualization. 
P regulation of energy metabolism during decidualization 
Our studies uncovered an interesting link between PR signaling and regulation of energy 
metabolism during decidualization. Critical endometrial functions, such as proliferation, 
differentiation and apoptosis are energy demanding processes. Growing evidence suggests that 
the regulation of energy metabolism is essential for the establishment of successful pregnancy 
[18]. For example, an adequate level of glucose is necessary for proper stromal differentiation. 
During in vitro differentiation of mouse and human stromal cells, the differentiation process is 
impaired when the glucose levels in the culture medium are depleted [19]. Several facilitative 
glucose transporters (GLUTs), which control cellular glucose uptake, are expressed in the 
endometrial stroma [19]. SLC2A1 (GLUT1) mRNA was found to be the most abundant in 
stromal cells and its expression was shown to be required for in vitro differentiation of human 
stromal cells [19]. Interestingly, women with idiopathic infertility were shown to have 
significantly lower levels of SLC2A1 in their stroma than controls with non-endometrial 
infertility [20], suggesting that decreased glucose uptake might contribute to impaired stromal 
differentiation and lead to impaired endometrial function and infertility in these patients. The 
expression of SLC2A8 (GLUT8) mRNA in both mouse and human stromal cells was reported to 
increase dramatically in response to the hormonal changes that occur during the process of 
implantation. The ovaries of Slc2a8 (-/-) mice exhibited abnormal metabolism and ATP 
production. Down regulation of SLC2A8 expression in human endometrial stromal cells resulted 
in impaired differentiation [21], suggesting that the GLUTs play an important role in meeting the 
increased demand for glucose during this process. Our gene expression profiling studies revealed 
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that the expressions of glucose transporters SLC2A3 (GLUT3) and SLC2A11 (GLUT10, 
GLUT11) were modestly up regulated by PRB, suggesting that P signaling might be involved in 
the regulation of glucose uptake. Further studies, addressing the functional roles of these 
GLUTS, are necessary to clarify the link between PR signaling and regulation of glucose uptake. 
In addition to the GLUTs, our microarray analysis indicated that the insulin receptor 
substrate 2 (IRS2), an adaptor substrate for insulin and insulin-like growth factor-1 receptors, is a 
P-regulated gene. Insulin signaling is a major regulator of cellular glucose uptake. Binding of 
insulin to its receptor tyrosine kinase triggers phosphorylation of insulin receptor substrates (IRS 
family). The phosphorylated tyrosine residues on the IRS proteins become docking sites for 
several downstream signaling molecules, such as PI3K and GRB3. In muscle cells and 
adipocytes, signaling via these pathways control critical processes, including cell survival, 
glycogen synthesis/breakdown and translocation of GLUT4 to plasma membrane. Certain 
reproductive disorders are associated with impaired insulin metabolism. For example, polycystic 
ovary syndrome (PCOS), a female endocrine disorder, is characterized by cystic ovaries, 
excessive amounts of androgenic hormones, and decreased or no ovulation. PCOS patients also 
have higher rates of insulin resistance, miscarriage and obesity [22, 23]. Although the major 
cause of the infertility is thought to be an ovarian defect, the reasons for the high incidence of 
miscarriage in PCOS remain unclear. Defects in certain components of the insulin-signaling 
pathway, including excess phosphorylation of the insulin receptor and lower levels of IRS1 and 
GLUT4, have been reported in the endometrium of PCOS patients with hyperinsulinemia [24, 
25], suggesting that impaired insulin signaling may lead to impaired endometrial function and 
fertility problems.  
Our results indicated that IRS2 serves as an important regulator of energy metabolism 
during decidualization. Using ChIP-seq and gene expression analyses, we identified IRS2 as a 
potential direct target of both PRA and PRB. These findings are consistent with previous reports 
indicating a role of P in regulating IRS2 expression, which was further linked to insulin-like 
growth factor signaling [26-28]. In human endometrial stromal cells, expression and 
phosphorylation of IRS2 increased during in vitro decidualization [29], suggesting that it might 
play a critical role during the differentiation process. 
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Development of the Irs2 null mouse underlined the importance of energy metabolism in 
regulation of female fertility [30]. Irs2 (-/-) female mice were infertile. Infertility was thought to 
be due to an ovarian defect.  Levels of E, P, and the gonadotropins were also low in these 
animals. The status of decidualization in the Irs2 (-/-) mice is not known. In human endometrial 
stromal cells, we showed that the loss of IRS2 expression led to impaired differentiation, 
suggesting an important role for IRS2 in human decidualization. We propose that IRS2 is a 
critical link between PR signaling and energy metabolism during stromal differentiation. IRS2 
may be involved in localization of glucose transporters to the cell membrane to enable the 
endometrial stromal cells to take up enough glucose to meet the increased energy needs during 
their proliferation and differentiation. Future studies, addressing the level and localization of 
glucose transporters in stromal cells lacking IRS2, would be useful to test this possibility. IRS2 
may also be involved in the regulation of genes controlling glucose metabolism. In a recent 
study, it was shown that IRS2 is required for the expression of glucokinase and glucokinase 
regulatory protein in the liver [31]. We will, therefore, investigate whether IRS2 regulates the 
expression of key enzymes involved in glucose metabolism, such as hexokinase, 
phosphofructokinase and pyruvate kinase, during human stromal decidualization.  
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